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Abstract 
 
The stroke is one of the leading causes of morbidity and mortality or disability among 
adult population world-wide. Today, the advances in acute medical management of 
stroke are changing the neurological population. The percentage of individuals that suf-
fered stroke and survived the first month has increase to more than 85%. Therefore, it is 
critical to find clinically sustainable approaches to improve survivors’ quality of live, 
starting with the most important; walking.  
 
The current evidence shows that many stroke survivors have improved their walking 
after receiving therapeutic gait training utilizing various modalities in research in re-
search programs internationally, regardless of the time elapsed since their disease onset. 
One of these recognizable modalities is a functional electrical stimulation (FES), how-
ever, despite its common availability compared with expensive robot-based therapies, its 
use is rather limited world-wide, mainly due to lack of training. 
 
This study is divided into three parts. First, a systematized review is presented to provide 
evidence concerning the use of FES-walking therapy in stroke rehabilitation. Results re-
lated to changes in gait speed and participants’ satisfactions compared with the use of 
standard ankle foot orthosis are provided. Second, a case study involving 5 weeks of 
FES-walking therapy is presented to assess the feasibility of this approach in a school 
setting so that the gained knowledge can be applied in standard clinical practice. 
 
The results of this work show that there is enough evidence to apply the FES-walking 
therapy in rehabilitation setting and that even and individual 14 years post stroke can 
improve gait pattern significantly. Nevertheless, the problem remains in the lack of train-
ing of pertinent physiotherapists and their believes towards this type of therapy modality. 
Therefore, the author hopes that this work can be used as the first step towards successful 
incorporation of this modality in standard stroke rehabilitation in Finland. 
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1 INTRODUCTION 
Today, the advances in acute medical management of stroke are changing the neuro-
logical population. The percentage of individuals that suffered stroke and survived the 
first month has increase to more than 85% (Meretoja et al. 2011). The activity-depend-
ent plasticity of the neural pathways, previously thought to be unresponsive and with-
out ability to recover, gives us the example how the scientific evidence can challenge 
the assumptions of current clinical practice (Behrman, Bowden & Nair 2006). Activ-
ity-based gait therapy, combining research on neural plasticity and the role of spinal 
cord in stepping and standing is applied to Locomotor Training (LT). LT works to 
“awaken” dormant neural pathways by repetitively stimulating the muscles and nerves 
in the lower body. LT is commonly used for stroke survivors and other neurological 
disorders. The current evidence shows that many stroke survivors have improved their 
walking after receiving therapeutic gait training utilizing various modalities (e.g., body 
weight-support treadmill (BWST) training, robot-based locomotor training) in re-
search programs and rehabilitation clinics internationally, regardless of the time 
elapsed since their disease onset (Mehrholz, Thomas & Elsner 2017). Nevertheless, 
these modalities require large amount of men power and/or expensive device as BWST 
or robot. 
 
Functional Electrical Stimulation based LT (FES-walking), on the other hand, can be 
used in conjunction with parallel bars or over ground walking; decreasing the need of 
expensive equipment. Further, the recent research has shown that stroke survivors have 
the capacity to improve voluntary walking function following short-term intensive 
FES therapy (Howlett, Lannin, Ada & McKinstry 2015; Masani & Popovic 2011). 
Furthermore, the positive effects seemed to be remaining even after therapy cessation 
(Howlett, Lannin, Ada & McKinstry 2015; Stein, Fritsch, Robinson, Sbruzzi & Plentz 
2015). Therefore, the FES-walking restorative therapy may be possibly used to en-
hance spinal neuroplasticity, instead of using it as a pure compensatory walking aid 
(e.g., Bioness or WalkAid) as was done in the past (Masani & Popovic 2011; Popovic 
& Thrasher 2004).  
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It has been reported that the FES-walking has positive effects on muscle density, qual-
ity of life and walking competence (Wilkie, Shiels, Bulley & Salisbury 2012), and also 
potential to emulate normal mechanical strains on bone during weight-bearing activity. 
These strains may stimulate bone formation through alterations in muscle activity that 
cannot be achieved with BWST- or robot-based LT training alone (Coupaud, Jack, 
Hunt & Allan 2009).  
 
The first electrical stimulation for drop foot prevention in stroke survivors was intro-
duced already in 1961 (Liberson, Holmquest, Scot & Dow 1961) and benefits of the 
FES therapies among stroke survivor population compared with conventional exercise 
programs have been described elsewhere (Howlett, Lannin, Ada & McKinstry 2015; 
Mehrholz, Thomas & Elsner 2017). Nevertheless, the use of neuromuscular stimula-
tion among physiotherapists and especially in task-oriented therapies (including ther-
apeutic goals as walking, arm function, muscle strength, endurance and sensation, pre-
vention of shoulder subluxation, or decrease of spasticity) is still low. This is mainly 
due to a lack of training (inability to use the stimulation with proper setting for execu-
tion of intended tasks), time and equipment. (Auchstaetter et al. 2016.) 
 
In Canada, this limitation has been recently recognized and recommendations concern-
ing incorporation of FES, as one of the key components of activity-based therapy, into 
the mainstream health care and community programs have been made (Behrman, Ar-
dolino & Harkema 2017). In addition, the use of FES is now included in the Canadian 
best practice accreditation guidelines in Stroke rehabilitation (Teasell et al. 2020). 
Therefore, this thesis is proposed to introduce the FES in Finland, show potential ap-
plications and find out whether potential patients would be satisfied with the FES-
walking therapeutic approach if used clinically. 
 
This work is organized as follows. In the second chapter, a brief description of stroke 
disease, its consequences, as well as possible therapeutic modalities including FES is 
provided. The third chapter presents insight into recent research concerning FES ther-
apies used in stroke gait rehabilitation via systematized literature review. In the fourth 
chapter, a case study performed at school facilities and its results (satisfaction with the 
therapy) is described. All the results are discussed and concluded in the fifth and sixth 
chapters, respectively. In the last chapter, future prospects are discussed. 
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2 BACKGROUND 
2.1 Stroke 
The stroke is one of the leading causes of morbidity and mortality or disability among 
adult population world-wide. The incidence rate of stroke is about 800 thousand and 1 
million of people per year in USA and EU, respectively, estimating that 1 of 6 people 
will suffer stroke in their lifetime. Although, the surviving rate is increasing, the stroke 
still accounts for 11.8% of total deaths world-wide, the second leading cause of dead 
globally. (Benjamin et al. 2018.) Further, over 50% of individuals suffering stroke 
remain with residual disability requiring an assistance for activities of daily living that 
causes a large burden on health and social care systems (Website of American Stroke 
association 2020; Website of World Health Organization 2019; Krupinski, Secades & 
Shiraliyeva 2014). 
 
The definition of stroke as ”a rapidly developing clinical signs of focal (or global) 
disturbance of cerebral function lasting 24 hours or longer of leading to death, with no 
apparent cause other than of vascular origin” by World Health Organization was pro-
vided in 1970 (Coupland, Thapar, Qureshi, Jenkins & Davies 2017). 
 
In other words, the stroke is a disease that is caused by either blocking or rupturing 
blood vessels and therefore limiting or interrupting blood supply coming to the brain. 
As a consequence of this cut in blood supply, the brain doesn’t get enough oxygen 
causing necrosis of the brain tissue. Based on the stroke’s etiology, two major types of 
strokes are recognized, hemorrhagic and ischemic. The hemorrhagic stroke is caused 
by a rupture of a blood vessel when blood is pouring into the brain tissue damaging it. 
While the ischemic stroke is caused by an infarction of a blood vessel similarly to a 
heart attack. A cloth or a plaque formed by fatty deposits is obstructing the blood flow 
to brain causing death of brain cells. The risks of stroke development are primarily 
related to lifestyle factors as smoking, unhealthy diet or low physical activity levels 
but also linked to clinical factors such as abdominal obesity. (Website of American 
Stroke association 2020; Website of World Health Organization 2019.)  
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2.2 Stroke consequences 
The brain is a very complex tissue therefore the stroke consequences are primarily 
dependent on the nature (hemorrhagic/ischemic), location of the blood supply inter-
ruption (sensorial, motor or cognitive systems) and the extent of the brain tissue that 
was damaged (magnitude of the functional impact). The damage in different brain lo-
cations may cause problems as altered feeling (e.g., cold/hot, sharp/dull), articulation 
deficiency or loss of voluntary motor functions (e.g., flaccid or spastic limbs). In ad-
dition, the patient’s condition prior stroke’s onset and the time poststroke are factors 
that also affect the extent of recovery. (Prieto, Cano-de-la-Cuerda, López-Larraz, Me-
trot, Molinari & van Dokkum 2014.) 
 
When considering damage of motor cortex, the stroke usually affects only one side of 
the cerebral hemisphere resulting in partial (hemiparesis) or complete paralysis (hem-
iplegia) of the opposite side of the body. The consequences may range from very mild 
hemiparesis (the voluntary functions are almost preserved) to severe hemiplegia that 
causes radical reduction or loss of the voluntary functions. (Website of American 
Stroke association 2020.) 
2.3 Physiotherapy approaches used in stroke rehabilitation 
The post-stroke physiotherapy and its goals is very dependent on the phase of recovery 
process. The process can be divided into 4 main stages: acute, early, late and chronic 
rehabilitation. In the acute stage, hours after the event, the main goal is to start mobi-
lization of affected limbs. In the early stage, up to 3 months post stroke, the main goal 
moves to increase individual’s activities of daily living and participation by re-educa-
tion of movement patterns or teaching compensatory strategies if needed. In the late 
stage, up to 6 months post stroke, the main goal is further focused on decreasing indi-
vidual’s limitation in activities of daily living and participation. In the chronic stage, 
beyond 6 months post stroke, the main rehabilitation goal moves from direct physio-
therapy towards support and counseling how to cope with the disability in everyday 
situation. Although, physiotherapist still concentrate on maintaining or improvement 
of functional capacity. (Veerbeek et al. 2014a; Winstein et al. 2016.) See Figure 1 for 
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graphical representation of the recovery process and timing of particular rehabilitation 
stages.  
 
 
Figure 1: Hypothetical stroke recovery pattern together with goals of intervention for 
particular time slots. Reprinted from The Lancet (Langhorne, Bernhardt & Kwakkel 
2011) with permission from Elsevier. 
 
As can be seen from the Figure 1, the post-stroke recovery follows rather a nonlinear 
logarithmic pattern. Despite reports of improvements in later rehabilitation stages, it 
has been shown that the spontaneous recovery together with the greatest physiotherapy 
outcomes happens during the first 3 months post-stroke (Teasell et al. 2020; Veerbeek 
et al. 2014a; Winstein et al. 2016). Therefore, the rehabilitation aiming at the improve-
ment of individual’s physical/cognitive condition, should be very intensive in this rel-
atively short time window (Coleman et al. 2017).  
 
Today, a large variety of treatment concepts is used in stroke rehabilitation. Particular 
concepts are believed to be superior to others by different schools of physiotherapy, 
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especially what considers development of motor learning (Teasell et al. 2020; Veer-
beek et al. 2014a; Winstein et al. 2016). Nevertheless, results of systematic reviews 
and meta-analyses suggest that the intensive and high repetitive task-oriented/activity-
based training – the combination therapies – may have better outcomes when com-
pared with single concept approach (Belda-Lois et al. 2011; Hatem et al. 2016; Prieto, 
Cano-de-la-Cuerda, López-Larraz, Metrot, Molinari & van Dokkum 2014; Veerbeek 
et al. 2014b). Among these combination therapies for improvement of walking com-
petences is the body-weight supported treadmill training and electromechanically-as-
sisted gait training with FES (Veerbeek et al. 2014b). 
2.4 Electrical Stimulation 
2.4.1 General overview 
Electrical stimulation is a technique that is using an external device able to generate 
current pulses (~ up to 200 mA). The current is then delivered to the body tissues (e.g., 
muscle, nerves) through leads and surface self-adhesive or implanted electrodes placed 
at appropriate (task specific) locations. The size, shape and frequency of the current 
pulses depend on the stimulated tissue and desired goals of the stimulation. Generally, 
the stimulation can be used in wide variety of clinical applications as muscle strength-
ening and re-education, wound healing, resolving inflammations and edema, pain con-
trol or enhancing drug delivery. Nevertheless, in physical rehabilitation, the use of the 
electrical stimulation can be divided into 3 main categories: transcutaneous electrical 
nerve stimulation (TENS), neuromuscular electrical stimulation (NMES), and func-
tional electrical stimulation (FES). (Cameron, Shapiro & Ocelnik 2018.) 
 
The TENS category of the electrical stimulation is primarily used for either pain con-
trol or tissue healing, although, some studies have successfully used TENS for trigger-
ing neuroplasticity (Veerbeek et al. 2014b). The TENS uses either very high frequen-
cies with short pulse duration or very low frequencies with longer pulses. Therefore, 
this type of stimulation is not sufficient for triggering constant muscle tetanic reaction. 
(Cameron, Shapiro & Ocelnik 2018.) 
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The NMES and FES terms are used interchangeably throughout the literature as au-
thors define what is a functional exercise according their own believes. Nevertheless, 
the recent definition provided in guidelines for the Bone health and Osteoporosis Man-
agement of Adults with Spinal Cord Injury by the Paralyzed Veterans of America is 
as follows: “the NMES is defined as the application of an electrical current of sufficient 
intensity to elicit muscle contraction while FES refers to the process of pairing NMES 
simultaneously or intermittently with a functional task, such as grasping and moving 
objects, cycling or rowing” (personal correspondence). This definition is very im-
portant as the current research evidence suggest that only the stimulation combined 
with functional task is providing sufficient stimulation to trigger neuroplasticity 
(Dolbow et al. 2015) 
 
As mentioned above, there is a large variety of current pulse parameters that need to 
be set according to the application. These parameters include current waveform, am-
plitude (strength), pulse width (duration), pulse frequency, pulse ramp-up and ramp-
down time and on/off time. Their correct setting is vital for successful competition of 
desired tasks. Although, the theory largely exceeds the limits of this thesis, the setting 
of these stimulation parameters is very straightforward and the summary of recom-
mended setup for various applications, as suggested by Cameron et al. (Cameron, 
Shapiro & Ocelnik 2018), is provided in Table 1. In following lines, only brief defini-
tion of the parameters and their connection to stimulation of the peripheral nervous 
system (to produce muscle contractions) as described in book by Cameron et al. will 
be provided. More extensive information can be found elsewhere (Baker 2000). 
2.4.2 Stimulation parameters 
Waveform: the biphasic symmetric or asymmetric current pulses are the most common 
waveforms used in neuromuscular stimulation. The symmetrical setting is used for 
stimulation of larger muscle groups (e.g., quadriceps) when both electrodes are placed 
on the muscle belly and equal stimulation under both electrodes is necessary to activate 
the large muscle bulk. The asymmetrical setting, on the other hand, is used for stimu-
lation of smaller muscles (e.g., extensor digitorum or opponens pollicis) when 
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stimulation just under the specific (small) muscle belly is desired. (Cameron, Shapiro 
& Ocelnik 2018.) 
 
Pulse amplitude: is the strength of the current, usually measured in milliamperes (mA). 
Higher the amplitude, higher the amount of current delivered to the tissue. Conse-
quently, more motor units are recruited, and larger muscle force is generated. (Cam-
eron, Shapiro & Ocelnik 2018.) 
 
Pulse width: the duration of the pulse positively affects the amount of total current 
delivered to the tissue (longer the pulse duration higher the amount of delivered cur-
rent). Generally, the larger muscle groups need higher amount of delivered current. 
Therefore, a longer pulse duration is required to generate proper muscle response. In 
case of smaller muscles or nerves, a shorter pulse duration is sufficient to trigger the 
desired response. Nevertheless, there is also a minimum combination of pulse duration 
and current amplitude that needs to be considered (Figure 2). As can be clearly seen, 
if very short pulse duration (~ 40 µs) is selected, only sensory stimulation of muscle 
group can be achieved, no matter of the current strength. For motor response in inner-
vated muscles, pulse duration between 150 to 350 µs is selected. However, shorter 
pulse duration requires greater current amplitude to produce same contraction strength 
as when longer pulse duration is used. (Cameron, Shapiro & Ocelnik 2018.) 
 
Pulse frequency: it is the amount of pulses per second. In case of symmetrical or asym-
metrical waveform, unit Hertz (Hz) or pulse per second (pps) is used, respectively. As 
can be seen from Figure 3, frequency above 30 Hz/pps is required to achieve smooth 
tetanic muscle contraction. Increase in the frequency above ~50 Hz/pps will result in 
greater muscle contraction (strength). Nevertheless, this will also result in more rapid 
muscle fatigue – time during which muscle will sufficiently react to stimulation will 
decrease (Figure 4). Therefore, endurance types of activities (e.g., walking, cycling, 
rowing) require lower frequencies of stimulation (~ 30 Hz/pps). (Cameron, Shapiro & 
Ocelnik 2018.) 
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Figure 2: The relationship between current intensity and pulse duration for creating of 
an action potential in various nerve types. Adapted from (Cameron, Shapiro & Ocelnik 
2018) with permission from Elsevier. 
 
 
 
 
Figure 3: Type of muscle contractions in relation to the frequency of stimulation. 
Adapted from (Cameron, Shapiro & Ocelnik 2018) with permission from Elsevier 
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Figure 4: The relation between number and strength of triggered muscle contractions 
depending on used stimulation frequency. Adapted from (Dreibati, Lavet, Pinti & 
Poumarat 2010) with permission from Elsevier Masson SAS. 
 
Pulse ramp-up/down time: is the time it takes for the stimulation current to increase 
from zero intensity to the one set on the stimulator and vice versa. This gradual in-
crease/decrease of the current allows for gradual increase/decrease of muscle contrac-
tion and consequently mimic increase/relaxation of voluntary muscle contraction. 
Longer ramp-up/down times (> 2s) are used to ensure stimulation comfort, especially 
for individuals with muscle spasticity for whom sudden change in electrical stimula-
tion (sudden muscle contraction) could cause increase in muscle spasticity or even 
injury. Nevertheless, curtain activities, where rapid contraction and relaxation is 
needed (e.g., gait training), require shorter ramp-up/down times (< 0.5s). (Cameron, 
Shapiro & Ocelnik 2018.) 
 
On/off stimulation time: is the time during which the stimulation occurs resulting in 
muscle contraction or the current flow is interrupted (relaxation time for the muscle), 
respectively. The relaxation time (off time) is needed to limit the muscle fatigue. In 
strengthening protocols, the ratio between on/off time (duty cycle) is usually 1:5 at the 
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beginning of the therapy. Later, the duty cycle decreases to 1:3 or even 1:2. In func-
tional activities as gait training, the duty cycle highly deepens on speed of locomotion 
or performed movement. For treatment of spasticity, duty cycle of 1:1 is generally 
used. (Cameron, Shapiro & Ocelnik 2018.) 
3 LITERATURE REVIEW 
3.1 Aim of the review 
Due to the current lack of use of FES treatment in stroke rehabilitation in Finland, a 
systematized literature search was conducted to provide insight into this neglected tool 
of neurological physiotherapy. Based on the synthesis of identified literature, out-
comes related to change of participants’ walking speed and satisfaction with therapy 
were evaluated to clearly outline the therapy benefits. Considering the large variety of 
electrical-related studies, only in-vivo human studies and those related to facilitation 
of walking during locomotor treatment of stroke survivors were the focus of this re-
view. 
3.2 Methodology 
A systematized literature search for peer-reviewed articles was conducted in PubMed. 
The search included all published reports from 1946 August 23rd ,2019. The search 
strategy used the following term to maximize manuscript capture of relevant articles 
and minimize inclusion of irrelevant records:  
 
(stroke [MeSH Terms] OR acute stroke [MeSH Terms] OR cerebral stroke [MeSH 
Terms] OR brain attack [Title/Abstract] OR (ischemic* [Title/Abstract] AND (stroke* 
[Title/Abstract] OR cerebrovascular syndrome* [Title/Abstract])) OR hemorrhagic 
stroke* [Title/Abstract]) AND (electrical stimulation [MeSH Terms] OR FES [Ti-
tle/Abstract] OR NMES [Title/Abstract] OR (functional [Title/Abstract] AND electri-
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cal [Title/Abstract] AND stimulation [Title/Abstract]) OR (neuromusc* [Title/Ab-
stract] AND electrical [Title/Abstract] AND stimulation [Title/Abstract])) AND (gait 
[Title/Abstract] OR walking [Title/Abstract] OR locomotion [Title/Abstract]). 
 
A total of 169 references were identified. However, the search failed to identify two 
articles on related topic known to the author (Jung_2018, Springer et al. 2013). There-
fore, these articles were also included in the review; having 171 articles in total. 
3.3 Selection process 
First level of the review focused on screening of abstract title and body of identified 
studies. During this step, the animal studies not excluded by the search strategy (n = 
4), non-English written studies (n = 9), case or case series (n = 14), commentary, re-
views or metanalyses (n = 22), studies reporting technical solutions (n = 12), upper 
limb- related rehabilitation study (n = 1), modeling studies (n = 2), studies using me-
chanical orthosis (n = 1), conference papers (n = 5), studies using stimulation for other 
goals than gait – strength training, balance, cycling etc. (n = 15), studies reporting 
development of activity assessment measures (n = 7), or other interventions than FES 
(n = 17) were eliminated. 
 
The second level review concentrated on the results sections of the all remaining arti-
cles (n = 61) to identify those articles that report participant’s satisfaction with FES 
treatment and/or changes in gait speed. During the second step, studies describing only 
one time trials (n = 7), case or case series (n = 2), studies involving implanted elec-
trodes (n = 8), studies not using FES training (n = 1), studies reporting other results 
than satisfaction and gait speed (n = 8) or studies that used FES in supine or side-lying 
position (n = 4) were also eliminated. Therefore, in the final review, data from 31 
articles are included. Detailed article screening process is illustrated in Figure 5. 
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Figure 5: PRISMA flow chart for article inclusion process 
 
3.4 Appraisal of evidence 
The following information was abstracted from the selected manuscripts: (1) the ma-
terial and method section were searched for references regarding participant popula-
tion (acute, sub-acute or chronic stage of disease, and number of participants), study 
type (RCT, pre-post longitudinal, cross-sectional or retrospective analysis), device 
used for stimulation, type of stimulation (number of channels and stimulation param-
eters), electrode placement, type of used switch, where the gait was trained, and details 
of intervention (length, number of sessions per week or session duration); and, (2) the 
results and discussion sections were searched for references regarding gait speed or 
satisfaction with therapy provided. In addition, these sections were also searched to 
find any reference regarding adverse events (number and type of adverse events). 
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3.5 Results 
3.5.1 Population and study design 
Of the 31 studies selected for inclusion in the review, 12 (39%) focused on chronic, 9 
(29%) on mixed sub-acute and chronic stroke population, 6 (19%) on sub-acute popu-
lation, 2 (6%) did not report the target population and only 2 (6%) studies involved 
population in acute phase of post-stroke. Over one third of the studies (42%) were 
randomized control trials (RCT) and pre-post longitudinal studies (39%). Neverthe-
less, approximately two thirds of the reviewed studies involved groups with less than 
20 individuals (65%). 
 
Out of 31 studies, 4 (13%) involved over 20 individuals (Everaert et al. 2013; Fer-
nandes, Carvalho & Prado 2006; van Swigchem, Vloothuis, den Boer, Weerdesteyn & 
Geurts 2010; Xu, Guo, Salem, Chen & Huang 2017), 3 (10%) involved over 50 indi-
viduals (O’Dell et al. 2014; Taylor, Humphreys & Swain 2013; Taylor et al. 1999a), 
and only 4 (13%) studies involved over 100 individuals (Bethoux et al. 2015, 2014; 
Street, Swain & Taylor 2017; Taylor et al. 1999b). Out of these 11 studies, only 3 were 
RCT (Bethoux et al. 2015, 2014; Xu, Guo, Salem, Chen & Huang 2017), 4 pre-post 
longitudinal studies (Fernandes, Carvalho & Prado 2006; O’Dell et al. 2014; Street, 
Swain & Taylor 2017; van Swigchem, Vloothuis, den Boer, Weerdesteyn & Geurts 
2010), 3 retrospective analyses (Taylor, Humphreys & Swain 2013; Taylor et al. 
1999a, 1999b) and 1 study with cross-over design (Everaert et al. 2013). 
3.5.2 FES stimulation 
Despite the importance of reporting used devices, 13 out of 31 studies (42%) did not 
report this important detail. Other studies were using either devices widely available 
on market for use by stroke survivors as WalkAide orthosis, Bioness L300 orthosis 
and Odstock Pace or 2-channel stimulator, or rarer/laboratory developed devices as 
Dorsiflex, CyberMedic and Grass S8800, 
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Twenty-three of the selected studies (75%) used only device with one channel, the 
majority (N = 21) for stimulation of common peroneal nerve (CPN) together with tib-
ialis anterior muscle (TA). Only 2 studies used one channel for stimulation of ham-
string to mobilize stiff knee (Tenniglo, Buurke, Prinsen, Kottink, Nene & Rietman 
2018) and foot-arch with dorsum to stimulate nociceptive withdrawal reflex (Spaich, 
Svaneborg, Jorgensen & Andersen 2014). 
 
Approximately one fourth (N = 8) of the reviewed studies used two channel stimulator, 
the majority for stimulating ankle dorsi and plantar flexors (Awad, Reisman, Kesar & 
Binder-Macleod 2014; Awad, Reisman, Pohlig & Binder-Macleod 2016; Hakansson, 
Kesar, Reisman, Binder-Macleod & Higginson 2011; Reisman et al. 2013). Other ap-
plications were stimulation of gluteus medius together with CPN+TA (Cho, Kim, 
Chung & Hwang 2015; Chung, Kim, Cha & Hwang 2014) and quadriceps femoris 
together with CPN+TA (Ng, Tong & Li 2008; Tong, Ng & Li 2006). 
 
While, it is important to report stimulation parameters as pulse frequency, duration and 
ramp time used for gait training, 14 studies (45%) did not report used frequency, 15 
studies (48%) pulse duration and 28 studies (90%) did not specify ramp-up/down 
times. From the remining studies, the majority (N = 10) used frequency of 40 Hz/pps 
and pulse duration of 200 µs (N =4) or 300 µs (N = 6). The ramp time of 0.3s was 
mentioned by two studies (Ng, Tong & Li 2008; Tong, Ng & Li 2006) and another 
study reported range of 0 – 2s (Sharif, Ghulam, Malik & Saeed 2017). 
3.5.3 Parameters of interventions 
Among studies included in the review, the length of intervention was very variable, 
ranging from 1 week to 48 weeks in case of RCT’s or longitudinal studies, and up to 
5 years in case of retrospective studies. Nevertheless, the most common (N = 8) length 
of intervention was 8 weeks (Awad, Reisman, Kesar & Binder-Macleod 2014; Awad, 
Reisman, Pohlig & Binder-Macleod 2016; Everaert et al. 2013; Hakansson, Kesar, 
Reisman, Binder-Macleod & Higginson 2011; Reisman et al. 2013; Sabut, Lenka, Ku-
mar & Mahadevappa 2010b; Sabut, Sikdar, Mondal, Kumar & Mahadevappa 2010a; 
Salisbury, Shiels, Todd & Dennis 2013). The number of therapy sessions was either 3 
20 
times or 5 times per week, or individuals used the stimulation daily during home ac-
tivities and community walking. These intensities of weekly trainings were rather 
equally distributed over review studies (~1/3 of studies per each group). 
 
In approximately 1/3 of reviewed studies (N = 9), the session duration lasted through-
out the day during home and community activities (Bethoux et al. 2015, 2014; Everaert 
et al. 2013; Gervasoni et al. 2017; O’Dell et al. 2014; Street, Swain & Taylor 2017; 
van Swigchem, Vloothuis, den Boer, Weerdesteyn & Geurts 2010; Taylor, Humphreys 
& Swain 2013; Taylor et al. 1999b). The second most commonly mentioned interven-
tion session was session lasting 30 min. without any additional specification of training 
program (N = 7). Two studies specified protocol either 4x6 min. with 1 min. on/off 
stimulation (Reisman et al. 2013) or 6x5 min. on stimulation with 5 min. break be-
tween sessions (Hakansson, Kesar, Reisman, Binder-Macleod & Higginson 2011) and 
2 studies reported therapy sessions lasting 30 min. that included 27 min. of treadmill 
training with 1 min. on/off stimulation plus 3 min. of over-ground walking without 
electrical stimulation (Awad, Reisman, Kesar & Binder-Macleod 2014; Awad, 
Reisman, Pohlig & Binder-Macleod 2016). 
3.5.4 Gait and satisfaction related outcomes 
The significant improvements in gait speed after intervention were reported in 18 of 
31 studies while 9 of 31 studies did not find any significant change. The typical im-
provement ranged from 0.1 to 0.18 m/s in 6 min. walk test and only 2 studies reported 
significant improvements in gait speed of 0.39 and 0.41 m/s in comparison with control 
group (Ng, Tong & Li 2008; Tong, Ng & Li 2006). Both these studies used FES to-
gether with a gait trainer. 
 
In only 1 of 8 studies reporting therapy satisfaction results authors found nonsignifi-
cant results of Stroke Impact Scale and Stroke Specific Quality of Life measures when 
comparing FES group with group that used standard ankle foot orthosis (AFO) 
throughout the intervention (Bethoux et al. 2014). In remaining studies, the satisfac-
tion with use of FES was significantly greater compared with use of AFO (Awad, 
Reisman, Kesar & Binder-Macleod 2014; Bulley, Shiels, Wilkie & Salisbury 2011; 
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Everaert et al. 2013; Fernandes, Carvalho & Prado 2006; O’Dell et al. 2014; van Swig-
chem, Vloothuis, den Boer, Weerdesteyn & Geurts 2010; Taylor et al. 1999a). The 
primary reasons for participants’ satisfaction were being able to move the ankle more 
freely, reduction in the effort of walking, quality of gait pattern, less likely to trip, and 
walking safely, independently and with greater confidentiality. Nevertheless, it has to 
be noted, some individuals were dissatisfied/frustrated with the device and stopped the 
treatment. The main reasons were difficult electrode positioning, skin-issues, deterio-
ration or mobility improvement and difficulty in use/placement of the equipment (“too 
much bother”). (Taylor et al. 1999a.) 
3.5.5 Adverse events 
Only 8 of 31 selected studies (26 %) reported serious adverse event as fall (Bethoux et 
al. 2015; Everaert et al. 2013; O’Dell et al. 2014), knee pain (Gervasoni et al. 2017), 
headache (Johnson, Burridge, Strike, Wood & Swain 2004; Johnson, Wood, Swain, 
Tromans, Strike & Burridge 2002), tendovaginitis of common peroneal nerve (van 
Swigchem, Vloothuis, den Boer, Weerdesteyn & Geurts 2010) or edema (Taylor et al. 
1999a) related to the intervention. Five out of 31 studies (16 %) reported that none of 
serious adverse events occurred. Nevertheless, the half, 15 of 31 studies (48 %), did 
not report any detail concerning this important issue. 
 
When reported (N = 10), the minor adverse events as skin irritation, muscle soreness, 
rash, discomfort, pain or skin allergy were relatively common. The occurrence ratios 
of these adverse events were not given with exception of one study by Taylor et al 
(Taylor et al. 1999a) were authors reported skin irritation in 22.3% of individuals in-
volved in their study. However, these events did not preclude participants from the 
therapy continuation and were usually resolved in matter of days. 
 
In summary, only 7 of 31 studies included larger populations (N > 50) and their results 
may provide unbiased insight into FES gait therapy effectiveness. Thus, the infor-
mation concerning these interventions, used stimulation and interventions’ results is 
provided in greater detail in Table 2.  
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4 INTERVENTION 
4.1 Study objectives 
The current study aims at feasibility assessment of implementing the FES-walking 
therapy for stroke survivors as the first step of knowledge translation from research to 
standard clinical practice in Finland. 
4.1.1 Primary objective 
The primary objective of this study is to assess feasibility of implementing the FES-
walking therapy in physiotherapy school setting. Specifically, a construct at a patient 
and program level will be tested: Safety, Adherence and Engagement (Table 3). 
 
Safety as defined as the relative freedom from harm. In this study it refers to an absence 
of harmful side effects resulting from the use of FES-walking therapy and may be 
assessed by adverse events and negative change in clinical outcome measures i.e. de-
creased physical capacity (the Rivermead Mobility Index as a functional independence 
measure). Safety and tolerability of the FES-walking therapy will be represented by 
the degree to which minor adverse effects can be tolerated by the participant. Fre-
quency of major adverse events will also be monitored to determine if they occur more 
frequently. 
 
Adherence as defined in this study is the extent to which the participant continues the 
agreed-upon mode of treatment, in this case the parameters of the FES-walking therapy 
under limited direction when faced with conflicting demands (i.e. attendance – 3 
days/week).  In the case of this study we will monitor frequency and duration of train-
ing sessions attended.   
 
Engagement, as defined in this study, is the emotional and intellectual involvement in 
the FES-walking therapy. For the patients we will use modification of the existing 
Patient Quality of Services Survey. 
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4.1.2 Secondary objective 
The secondary objective of this study is to evaluate self-reported quality of life (EQ-
5D), and changes in participants passive dorsiflexion and spasticity level of affected 
limb. 
 
Table 3: Summary of features collected for assessment of FES-walking implementa-
tion feasibility 
 
Criteria Safety Adherence Engagement 
Provider # Injuries during 
FES-walking 
# Consistency of trainer/par-
ticipant alignment 
# Training sessions 
attended 
# Issues addressed 
Participants # Minor/Major 
events 
documented 
# FES-walking sessions at-
tended 
# of discharges for FES-
walking 
# of withdrawals 
Out-patient Quality 
of Services Survey  
4.2 Site of Study 
The proposed study was conducted at the premises of the Satakunta University of Ap-
plied Science (SAMK, www.samk.fi) that included needed equipment, the body 
weight-supported treadmill, weight-supported over ground walking and/or parallel 
bars, for conduction of this study. 
4.3 Study design 
4.3.1 Study population 
The present study is a single case study that provides an information whether it is 
feasible to utilize FES-walking therapy as a standard therapeutic tool in clinical prac-
tice. The selection of a case study was primarily based on feasibility aspects of the 
bachelor level of this study. 
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Potential participants were identified based on discussion with local stroke community 
that participated at lectures of Neurological physiotherapy at SAMK. The participation 
in this case study was offered based on the following selection criteria to ensure that 
the participant has a potential to benefit from the program (see Table 4) and that has 
the capacity to participate fully in the sessions (see Table 4). Once deemed eligible 
participant was offered a start date (January 8th, 2020) and time to begin participation. 
The participant was a 55-year old male (right-handed) with left side hemiplegia as a 
consequence of hemorrhagic stroke 14 years ago. This study was permitted by the 
Ethical committee of Satakorkea on December 9th, 2019. The application files as well 
as the committee statement can be found in the Appendix 1. 
4.3.2 FES-walking therapy - implementation 
During the initial gait assessment, the participant showed signs of drop-foot, insuffi-
cient hip flexion and push-off at the terminal stance phase of the left lower limb. There-
fore, it was decided that the participant receives supportive stimulation of common 
peroneal nerve (CPN) together with tibialis anterior muscle (TA) on the left lower limb 
to trigger correction of drop-foot and flexion-withdrawal effect for better foot clear-
ance during the gait swing phase. In addition, participant’s left calf muscles (CA) was 
also stimulated to trigger push-off motion at the terminal stance phase and assist with 
knee flexion during the initial swing phase. 
 
The participant received 15 sessions each involving up to 40 minutes of FES stimula-
tion. Participant attended therapy 1 time per week during the first two weeks of inter-
vention, 2 times per week during the third week and 3 times per week during the rest 
of the intervention, 7 weeks in total.  
 
During the first three weeks (3 sessions in total), participant underwent a muscle 
strengthening (conditioning) protocol consisting of stimulation applied to the CPN, 
TA and CA muscles in 20-s duty cycles (i.e., 10 s extensors/dorsiflexion on and flex-
ors/plantarflexion off followed by 10 s extensors off and flexors on). These exercises 
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Table 4: Summary of inclusion and exclusion criteria for KIK-Walk study  
 
Inclusion criteria Exclusion criteria 
• Age ≥ 18 years and medically 
stable condition 
• Walking independently either with 
use of assistive devices or with 
speed < 0.5 m/s (preclusion of  
being community walker) during a 
2-minute walking test. 
• Willingness and possibility to  
participate in FES-walking therapy 
• Responsiveness to electrical stimu-
lation 
• Proximity to SAMK for realistic 
access 
• Access to reliable transportation 
 
• Bilateral stroke 
• Tendon lengthening surgery in the last 6 months. 
If greater than 6 months, require surgeon's  
approval 
• Contraindications to FES (cardiac pacemakers, 
skin scratches or grade 2 or 3 pressure ulcers at 
potential electrode sites, denervation of targeted 
muscles) 
• Grade 4 Pressure ulcers anywhere on the lower 
extremities 
• Uncontrolled Hypertension or symptoms of or-
thostatic hypotension when standing for 15 
minutes 
• Subjects with a history of cardiovascular dis-
ease, must obtain medical clearance from their 
primary care physician before inclusion 
• Amyotrophic Lateral Sclerosis or lower motor 
neuron disorders 
• Dependent on ventilator or unable to voluntarily 
extend head 
• Painful musculoskeletal dysfunction (e.g., knee 
deformity) or unhealed fractures 
• Fixed muscle contracture 
• Sensory or motor peripheral neuropathy 
• Unable to follow/understand verbal commands 
• Pregnancy 
• Psychological disorders 
• Uncontrolled seizure disorder 
• Illegal drug use  
• MRSA or other infectious diseases requiring 
contact droplet precautions 
• Active oncology diagnosis 
 
were performed in four sets of 5 min with 5-min rests in between, with exception of 
the third session when the participant was able to undergo five sets in row. The slower 
start of the therapy was selected due to excessive muscle fatigue present during the 
first weeks of stimulation. FES stimulation was delivered by a preprogramed 2-chan-
nel transcutaneous electric stimulator (Cefar Rehab X2, DJO Global Inc., Lewisville, 
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Texas, USA) using surface self-adhesive stimulation electrodes and automatically trig-
gered stimulation protocol. 
 
The electrodes of the FES stimulator were placed on the subject’s skin at the motor 
points above the nerves corresponding to the muscles targeted with FES (TA, CA) or 
the nerve (CPN) itself (Figure 6). Electrode size were selected according to the size of 
a muscle that needs to be activated: TA (electrode size, 2.5 x 2.5 cm), CPN (Ø 2 cm) 
and CA (2.5 x 2.5 cm). The stimulation used symmetrical, biphasic, current regulated 
pulses with 300 ms of pulse duration, ramp-up and ramp-down time of 0.2 s and at 
frequency of 35 Hz. The current varied based on muscle fatigue and stimulated site 
between 20 – 60 mA. When all targeted muscles were capable of creating joint move-
ment against gravity (i.e., strength of grade 3 or more), the muscle strengthening pro-
tocol was terminated and FES-walking therapy began. 
 
 
Figure 6: The electrode setup for stimulation of common peroneal nerve, tibialis an-
terior and calf muscles. The X denotes the head of fibula and vertical line the supe-
rior part of popliteal fossa. 
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The FES-walking therapy was performed on a treadmill with an overhead harness sys-
tem for safety reasons, taking seated breaks when desired. The body weight support 
was set such that it was sufficient to assist the participant to achieve standing without 
knees buckling. The harness was worn on the treadmill at all times for safety. 
 
The participant received 20–40 min of FES-walking therapy per session for 4 weeks, 
3 times per week, taking seated breaks when desired. The treadmill speed was selected 
by attending physiotherapy student with input from the participant so that the walking 
speed felt comfortable and safe. During therapy, advices concerning gait pattern and 
correct timing of muscle activation were given to facilitate proper gait. 
 
The FES stimulation was delivered by a 2-channel transcutaneous electric stimulator 
(O2CHS, Odstock Medical Ltd., Salisbury, UK) using surface self-adhesive stimula-
tion electrodes. The electrodes were of same size and were placed on the same spots 
as during conditioning program (Figure 6). The stimulation used asymmetrical bipha-
sic (TA and CPN) and symmetrical biphasic (CA), voltage regulated pulses with cur-
rent between 40 – 70 mA, ramp-up and ramp-down time of 0.2 s, and frequency of 35 
Hz. These parameters were individually tailored to guarantee the most optimal setting 
for gait cycle. The pulse duration varied between 150 – 350 ms based on muscle fatigue 
and stimulated site. 
 
The gait sequence was triggered using two footswitches, one placed under left heel 
and the second under 1st metatarsal of left foot, to guarantee more accurate timing of 
the stimulation. The participant was encouraged to produce the intended movement 
voluntarily in every step and the stimulation was automatically triggered with a short 
delay to promote participant’s own muscle activation. The TA and CPN stimulation 
began on toe off and with ramp-down time continued until toe strike. Calf stimulation 
started just after flat foot (toe strike) and continued to terminal stance. 
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4.3.3 Timeline and data collected 
The intervention/study began on January 8th, 2020 and last until February 19th, 2020. 
During the baseline visit (January 8th, 2020), the participant filled following self-re-
ported questionnaires (paper version) prior onset the actual intervention: 
• Self-reported quality of life (EQ-5D, Appendix 2) 
• Rivermead Mobility Index (RMI, Appendix 3) 
Further, the participant’s age, sex and duration of the disease was also recorded. 
 
During the whole intervention, the number of sessions (frequency), duration of training 
sessions attended, any occurring injuries or health issues were recorded. Next, the par-
ticipant was also asked to keep a self-administered diary and record any minor/major 
adverse event (AE) that occurred outside of the intervention site (e.g. falls, injuries 
even unrelated to the intervention itself). In addition, for additional safety reasons and 
to follow any progression in participant’s mobility, the RMI questionnaire was filled 
on weekly basis. 
 
After the therapy cessation (the 15th intervention session), the same questionnaires 
(EQ-5D and RMI) as during the baseline visit were administered. Further, a written 
form for self-reported survey of service quality was administered (Quality of Services 
Survey – Appendix 4) to gather participant’s opinion about underwent intervention. In 
addition, participant’s ankle mobility/spasticity was assessed to see whether the inter-
vention had any effect on these parameters in comparison to the state recorded during 
participant’s pre-intervention screening procedure (see details in Appendix 1).  
 
Detailed summary of intervention timeline together with timing of administered ques-
tionnaires can be found in Table 5. 
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Table 5: Summary of timeline of administered questionnaires and data collection dur-
ing intervention 
 
Week Date Session EQ-5D RMI 
AE 
reporting 
Therapy 
adherence 
QSS 
1 8.1.20 Baseline X X  X  
2 17.1.20 2   X X  
3 
22.1.20 3  X X X  
24.1.20 4   X X  
4 
27.1.20 5  X X X  
29.1.20 6   X X  
31.1.20 7   X X  
5 
3.2.20 8  X X X  
5.2.20 9   X X  
7.2.20 10   X X  
6 
10.2.20 11  X X X  
12.2.20 12   X X  
7 
17.2.20 13   X X  
19.2.20 14  X X X  
21.2.20 Follow up X  X X X 
 
EQ-5D – Self-reported quality of life, RMI – Rivermead Mobility Index, AE – adverse event, QSS – 
Quality of Service Survey 
4.4 Statistical analysis 
As this case study is primarily a qualitative study, only the changes in degrees of dor-
siflexion of affected limb and the score changes of RMI questionnaire and spasticity 
of the affected limb with respect to pre-screening and baseline data are given as de-
scriptive figures. Further, the amount of training sessions planned vs completed, and 
total, maximum and average time of stimulation as well as the number of minor events 
and description of issues addressed during training sessions is reported. In addition, 
the participant’s satisfaction with the therapy is presented by pinpointing relevant an-
swers from Quality of Service Survey completed at the end of the intervention. 
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4.5 Results 
The participant was 55-year old male (right-handed) with left side hemiplegia as a 
result of stroke 14 years ago. He followed the agreed mode of treatment and partici-
pated in all 15 planned therapy sessions (therapy adherence was 100%). There were 2 
conflicting events (from therapy provider site) during the course of the intervention, 
nevertheless, participant was always able to reschedule. The stimulation time varied 
from 20 to 35.5 min. with average duration of the FES intervention being 25 min and 
total time over course of 6 weeks was 65 min. of muscle conditioning and 315 min. of 
FES walking. The participants’ self-selected comfortable treadmill speed was set to 
0.8 km/h during the first week of the FES-walking therapy and to 1.0 km/h thereafter. 
Therapy adherence form can be seen in Appendix 5. 
 
The ankle testing after the therapy cessation showed that the passive range of motion 
in dorsiflexion increased from 0 degrees to 15 degrees, spasticity of plantar flexors 
decreased from score of 4 to 3 in modified Ashworth spasticity scale, clonus related 
muscle contractions as well as Babinski sign decreased (no reaction when stimulating 
plantar aspect of affected foot). 
 
The visual inspection of gait pattern (using AFO and wheeler) showed that partici-
pant’s stride with affected leg is longer and straighter than before, participant’s stride 
begins with clear heel-strike and no extensive leg circumduction was observed as prior 
the onset of the study – the participant was able to easily fit his affect leg between rear 
wheels of his wheeler during gait which was not feasible prior study initiation. The 
change of the gait pattern (the improvement in orthotic effect) during FES-walking 
therapy on body weight supported treadmill can be seen in video uploaded to YouTube 
account of Tomas Cervinka (https://youtu.be/vw1esl_3x6g). 
 
While RMI questionnaire did not show any changes in physical capacity over the 
course of the study – score was constantly at 12 out of 15 points (Appendix 3), the 
self-reported quality of life (EQ-5D) questionnaire showed improvement in indication 
of current state of health from 70% to 80% (Appendix 2). In addition, participant’s 
clear satisfaction with the therapy was expressed in the Modified Outpatient Quality 
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of Service Survey (Appendix 4). Specifically, participant would recommend the ther-
apy to a friend of colleague (score 8 of 10), he was very satisfied with researchers’ 
professionalism, care, time spent, attentiveness towards concerns, concern for privacy 
and transparency, quality of service and information provided. Further, in the open 
feedback field, participant provided following comments: “Feeling more relaxed”, 
“spasticity decreased”, “walking is straighter”, “sleeping got better”, “training was 
hard and tiring but effective”, “I am very pleased with training (10+) and I recommend 
it to the others”. 
 
During the therapy, no injuries occurred (related or unrelated to the therapy itself). The 
only reported adverse therapy effect was mild skin redness on areas were electrodes 
were placed with exception of one mild adverse event (stiff leg for 24h after the stim-
ulation) reported during week 6 (Appendix 6). The skin redness always disappeared 
by the end of the intervention day and participant fully recovered from limb stiffness 
after cancelling the 3rd therapy session during the week 6. In addition, researchers had 
to address 3 issues related to difficulties with triggering of the stimulation and one 
related to poor skin conductivity - too dry skin (Appendix 6). 
5 DISCUSSION 
5.1 Literature review 
5.1.1 Population and study design 
While the majority of studies selected for inclusion are randomized control trials, only 
two of them included populations larger than 50 individuals. One may question the 
undoubtedly difficulties in organizing proper RCTs, especially selection of appropriate 
participants that must be willing to undergo several weeks/months of intensive treat-
ment with a need to travel to rehabilitation facility and back home. However, the patter 
obtained from the abstracted data points towards more obvious reason, study costs. 
The only two RCTs describing results of one study with follow up for 2 years used a 
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FES-based foot-drop WalkAid orthosis from Axionbionics, LLC and 5 of other studies 
that involved over 50 individuals were using either FES-based orthosis from Bioness 
Inc. or Odstock Ldt. Thus, it seems that only producers of foot-drop correcting or-
thoses, having their interest in spreading their products, have enough financial power 
to support extensive research. Nevertheless, as the authors always reported their po-
tential conflict of interest, the author of this thesis leaves on the reader his/her position 
towards the study outcomes and their interpretation. 
 
To reader surprise, it may also appear illogical that only 2 studies focused on acute 
phase of stroke rehabilitation. While, it is true that the acute phase is the most optimal 
time to start the rehabilitation to increase individuals’ change for faster and significant 
motor recovery, it is also time with the largest spontaneous recovery – a window of 
enhanced natural neurophysiological repair and cortical reorganization (Coleman et al. 
2017). If studying outcomes of new therapy intervention in this phase, investigators 
need much greater contrast between the experimental intervention and standard care 
to be able to distinguish whether the improvements in motor recovery occurred as a 
consequence of tested therapy approach or whether the improvements were triggered 
spontaneously by body’s ability to “heal” itself (Stinear 2016). Therefore, majority of 
the authors prefer later phases of stroke recovery (sub-acute and chronic stage). During 
these phases, one may presume that spontaneous recovery is over and only the tested 
therapy approach may be accounted for all the gains or declinations in participant’s 
condition. Nevertheless, these studies can’t give us the needed knowledge about effi-
cacy and effectiveness of tested experimental therapies during the spontaneous recov-
ery phase. Consequently, their translation to acute clinical care can be controversial. 
(Stinear 2016.) 
5.1.2 Electrical stimulation  
The majority of the reviewed literature used a one-channel stimulator for correction of 
a drop foot. While, the drop foot (caused by dorsiflexor weakness of spasticity of plan-
tar flexors) is the major impairment occurring post stroke, it is commonly accompanied 
by spasticity or weakness of knee and hip flexors/extensors (Wade, Wood, Heller, 
Maggs & Langton Hewer 1987). Therefore, a simple correction of dorsiflexion would 
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not be sufficient for ground foot clearance during gait if knee is spastic and fully ex-
tended (Li, Francisco & Zhou 2018). 
 
The one-channel stimulation if applied to tibialis anterior and common peroneal nerve 
triggers the ankle dorsi flexion and flexion withdrawal reflex (a spinal reflex that 
causes a sudden withdrawal of leg from the potentially dangerous situation as stepping 
on a sharp object). Thus, this stimulation alone can address the major issue of hemi-
plegic gait (insufficient foot clearance of affected leg causing leg circumduction and/or 
hip hiking) by simultaneous stimulation of dorsiflexion and hip and knee flexion. This, 
together with readily availability of “easy to use” commercial products (WalkAid, Bi-
oness, Odstock Pace), is probably the cause of the extensive research in this field of 
FES application among stroke survivor population. Although, it is clear that stroke 
survivors would benefit from multi-channel stimulation simultaneously addressing (i) 
avoidance of plantar flexion during pre-swing “push off” phase (Awad, Reisman, 
Kesar & Binder-Macleod 2014; Awad, Reisman, Pohlig & Binder-Macleod 2016; 
Hakansson, Kesar, Reisman, Binder-Macleod & Higginson 2011; Reisman et al. 2013) 
that may happen when only dorsiflexion triggered by one-channel stimulation is used 
(Kesar et al. 2010), (ii) stabilization of quadriceps and/or hamstrings during stance 
phase (Ng, Tong & Li 2008; Tenniglo, Buurke, Prinsen, Kottink, Nene & Rietman 
2018; Tong, Ng & Li 2006), or (iii) stabilization of gluteus medius during stair walking 
(Cho, Kim, Chung & Hwang 2015; Chung, Kim, Cha & Hwang 2014). Nevertheless, 
the use of multi-channel stimulation requires more knowledge concerning device se-
lection and setup, and gait kinematics (Cameron, Shapiro & Ocelnik 2018).  
 
It is a common knowledge, repeated in professional conferences, that every study 
should provide complete information regarding used procedures to assure inter-study 
comparability and ensure reproducibility of future studies. Especially in clinical trials, 
underreporting can be seen as a scientific misconduct (Chalmers 1990). In the current 
review, this key reporting criteria was not followed in majority of included studies. 
Nevertheless, it is correct to note that not every stimulation parameter has to be re-
ported as their setting is highly individual depending on performed task, responsivity 
of targeted nerves or muscles, perceived magnitude of sensation during electrical stim-
ulation, and may vary in time (Cameron, Shapiro & Ocelnik 2018). Reporting ranges, 
in which parameter as stimulation intensity was set, would not provide any additional 
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information for design of future studies. Thus, only important parameters as stimula-
tion frequency or pulse duration that affect “rapidness” of fatigue of stimulated mus-
cles, used waveform pinpointing area of greater stimulation effect, or ramp-up/down 
times affecting swiftness of orthotic effect of stimulated muscles should be described 
in detail. 
 
One may speculate that this under-reporting is caused by the use of pertinent FES-
based foot-drop orthoses from companies as Axionbionics, LLC, Bioness, Inc. or Od-
stock, Ldt as their devices were use in over half of the studies selected for the review. 
Further, thirteen other studies did not report type of used stimulator but involved stim-
ulation of TA and CPN, hence the use of FES-based orthoses from above mentioned 
companies may be presumed. It may be that these companies consider parameter set 
up as their trade secret and do not provide it freely. However, as presented in Table 2, 
two studies related to Odstock, Ldt, (Street, Swain & Taylor 2017; Taylor et al. 1999a) 
reported stimulation frequency and pulse duration. Therefore, this under-reporting 
seems to be more related by dilatoriness in reporting in this field. 
5.1.3 Parameters of interventions 
The reviewed studies presented a large variety of intervention durations lasting from 
1 week up to 5 years long follow up in case of one retrospective study. “While the 
evidence regarding the optimal intensity of FES exercise therapy is currently unclear” 
(Teasell, Foley, Hussein, Salter, Cotoi & Richardson 2015), the common study dura-
tion (4 to 8 weeks), with training intensity of 3 – 5 sessions per week with session 
duration lasting ~30 min. corresponds to known timeline of muscular neuroadaptation 
and intermuscular coordination. The ability to activate more muscle fibers and an in-
crease in the firing rate of neural impulses coming to muscles stays behind increased 
muscular strength, coordination and improved balance, the key factors for gait re-ed-
ucation even among athletes (Davis & Futrell 2016). 
 
It is perhaps not surprising that studies with the longest duration (≥ 18 weeks) involved 
devices from the above mentioned 3 companies presenting their economic power and 
interest in knowing long-term rehabilitation effects of their devices. The economic 
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power can be also seen from the ability of these companies to provide their devices to 
study participants for the whole study duration. Therefore, the participants could wear 
the FES-orthosis throughout the day during their activities at home and community. 
This is especially important as recent evidence suggests that larger doses of FES exer-
cise therapy (higher training intensity) are associated with better motor function re-
covery (Hsu, Hu, Luh, Wang, Yip & Hsieh 2012). 
 
Of note, the Odstock, Ldt is a spinoff company of the Salisbury NHS Foundation Trust. 
Thus, their Pace stimulator is regularly offered to stroke survivors, those that can ben-
efit from this type of support (i.e., are able to stand up from sitting without assistance 
and to walk with our without assistive aid ~10 m), by NHS as an alternative to standard 
ankle-foot orthosis (personal communication). 
5.1.4 Outcomes of interventions 
Walking (gait) speed is one of measures commonly used in studies that investigate and 
assess benefits/downfalls of experimental therapies in stroke rehabilitation because 
this measure can help with assessment of an individual functional status, identification 
of those at-risk of adverse outcomes as falls and can be used as an overall health factor 
in various populations (Middleton, Fritz & Lusardi 2015). This interest is also caused 
by the inevitability of physical therapist to prepare stroke survivors for as independent 
living in community as possible.  
 
In 1995, Perry et al. (Perry, Garrett, Gronley & Mulroy 1995) defined functional cat-
egories of gait speed in stroke population as: “ < 0.4m/s, Household walking only; 0.4 
to 0.58 m/s, Most limited community walking; 0.59 to 0.79 m/s, Least limited com-
munity walking; ≥ 0.8 m/s, Community walking. As these cut-off values are relatively 
narrow, and studies usually involve only limited number of participants, it seems to be 
necessary to follow any changes in gait speeds during the studies with experimental 
rehabilitation thoroughly. It has been counted that for detection of gait speed change 
of 0.08 m/s (40% difference from 0.2 m/s which is the common speed at baseline of 
stroke rehabilitation) at 5% significance level, the study must include 32 individuals 
per study arm (group). This increases to 55 individuals if detection of speed change of 
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0.06 m/s is required. (Johnson, Wood, Swain, Tromans, Strike & Burridge 2002.) 
Therefore, the meaningful minimally clinically important speed difference of 0.1 m/s 
during 10 meter walking test and distance difference of 50 m for 6 minute walk test 
was estimated (Perera, Mody, Woodman & Studenski 2006). 
 
Nevertheless, the cut-off values as defined by Perry at al. (Perry, Garrett, Gronley & 
Mulroy 1995) may not be valid when we consider safe speeds for passing pedestrian 
crossings. This study leaves the impression that speeds over 0.8 m/s are sufficient for 
community walking without issues. Similarly, the study by Asher et al. (Asher, Aresu, 
Falaschetti & Mindell 2012) showed that the mean speeds of individuals over 65 years 
old were 0.9 m/s for male and 0.8 m/s for women. However, the same authors pointed 
out that most of the pedestrian crossings in UK are designed for speeds of 1.2 m/s 
(estimated average of normal walking speed in able-bodied population), leaving values 
bellow this threshold insufficient for safe community living. Notwithstanding the fact 
that the crossing speeds largely vary between countries, mean of 1.32 m/s in United 
States, range of 0.73 – 0.78 m/s in Singapore, mean of 0.44 m/s in Australia and range 
of 1.0 – 1.2 m/s in Ontario (Salbach et al. 2014), physical therapy should still focus on 
improving gait speed of stroke survivors so that they would be as close to value of 1.2 
m/s as possible at discharge. Although, such speed was only reached in the reviewed 
studies by those individuals with moderated to mild impairments at therapy onset. 
 
There are number of questionnaires that can be used to evaluate disability and health-
related quality of life after stroke. Among these, the most used are the stroke impact 
scale (Jenkinson, Fitzpatrick, Crocker & Peters 2013) and Stroke Specific Quality of 
Life (Williams, Weinberger, Harris, Clark & Biller 1999) that take into account rele-
vant domains as mental, physical, mobility, memory, participation etc. Surprisingly, 
only three studies included in the review used such questionnaires (Awad, Reisman, 
Kesar & Binder-Macleod 2014; Bethoux et al. 2014; Fernandes, Carvalho & Prado 
2006). The other studies focused on qualitative outcomes to describe individuals’ self-
perception (attitudes, preferences, comfort, issues or safety) of underwent therapies. 
Although, nearly all reported outcomes only favoring the FES-based therapy, someone 
can question these results because lack of quantitative data (“numbers in black and 
white”). Nevertheless, as one can’t predict the study outcomes and it is very hard to 
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develop pertinent questionnaires to assess an individual’s self-perception, the qualita-
tive approach allowing free “mind” expression  may be suitable for these studies in 
this context (Hammarberg, Kirkman & de Lacey 2016).  
5.1.5 Adverse events 
Reporting of adverse events is a crucial component of good clinical practice (GCP) 
guidelines. The transparent and accurate reporting of adverse events is a key factor for 
“patient safety considerations as well as the importance of balancing assessments of 
efficacy versus risk profile for therapeutic interventions in clinical trials”. (Miller 
2012,) While it is constantly reminded throughout the scientific community and man-
dated by research ethics boards, adverse events remain under documented.  
 
When evaluating included articles, one could think that adverse event reporting im-
proved throughout the time and the most recent publications will follow the GCP 
guidelines. However, this is not the case. Even the recent publications from year 2017 
(Sharif, Ghulam, Malik & Saeed 2017; Xu, Guo, Salem, Chen & Huang 2017) did not 
provide any commentary concerning this important issue. One may speculate that the 
authors wanted to conceal a serious adverse event potentially “harming” the experi-
mental therapy design. Nevertheless, the occurrence of such events among reviewed 
studies is less than 0.01%, pointing more at the authors’ inactivity towards accurate 
reporting. Especially in cases when serious adverse events did not occur and a simple 
note (no adverse events occurred during the intervention) would suffice. 
 
One may also question the seemingly high rate or minor events as skin irritation that 
occurred in nearly one fourth of the study participants (Taylor et al. 1999a). Neverthe-
less, the 10-year follow up study, showed that the occurrence of this adverse event was 
reduced among users of Odstock Pace FES-orthosis to only 2.4% (Dalton & Taylor 
2011). 
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5.2 KIK-walk intervention 
5.2.1 Therapy adherence 
The current study reported 100% adherence to therapy plan without participant’s with-
drawal during ongoing intervention. This is mainly cause by the nature of the super-
vised case study and participant’s high motivation to try new therapy approach that 
could lead to improvement of his life quality. Nevertheless, among longitudinal stud-
ies, the therapy adherence rates (proportion of attended planned sessions) usually vary 
from 65% to 90% (mean of 77%) depending on whether the therapy is supervised or 
individual, and whether the therapy uses clinic-based or home-based program design 
with home-based supervised program having the higher rates (Bullard, Ji, An, Trinh, 
Mackenzie & Mullen 2019; Picorelli, Pereira, Pereira, Felício & Sherrington 2014). 
The dropout rate (proportion of individuals exiting the program prior cessation of the 
intervention) is generally very low, reaching up to 5% at maximum (Bullard, Ji, An, 
Trinh, Mackenzie & Mullen 2019). 
5.2.2 Changes in body structures and function 
The FES-based therapies showed their effectivity in gait rehabilitation when consider-
ing aspects as activity and participation, and are therefore recommended by number of 
stroke rehabilitation guidelines (Teasell et al. 2020; Veerbeek et al. 2014a; Winstein 
et al. 2016). Nevertheless, the benefits in body structures and function domain are not 
that clear when compared with other gait rehabilitation approaches (Pereira, Mehta, 
McIntyre, Lobo & Teasell 2012). 
 
The re-testing of ankle dorsiflexion showed that the 6-week intervention program was 
sufficient for decreasing participant’s plantar flexor spasticity and consequently ankle 
passive range of motion. This finding is in line with previous study by Sabut et al. 
(Sabut, Sikdar, Kumar & Mahadevappa 2011) where authors reported greater im-
provements in voluntary ankle dorsiflexion, plantar flexor spasticity and dorsiflexor 
strength when FES stimulation was used in addition to conventional rehabilitation over 
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course of 12-week intervention study. To date, however, it seems to be the only study 
addressing this issue (van der Linden & Mercer 2017).  
 
Already during the ongoing intervention, the author noted some changes (reduction in 
leg circumduction, hip hiking and visible heal strike) when participant walked (having 
AFO) towards his car post intervention session. These changes further improved until 
the intervention cessation and were also noted by the participant. Participant described 
the change as if his affected leg would go straighter during walking and that he can fit 
it in between rear wheels of his wheeler. Further, he pointed out that his leg feels less 
stiff and AFO is making clicking sounds during terminal stance of his gait. Although, 
this study did not involve any proper video analysis of participant’s gait, the increase 
in orthotic effect and consequently the improvement in walking pattern (e.g., visible 
heel strike, increased weight-shift to the affected site, reduced leg circumduction and 
hip hiking) over the course of the study is clearly visible from the short recording of 
participant’s gait on the treadmill. These outcomes have been also recognized previ-
ously during FES-based gait rehabilitation (Sabut, Lenka, Kumar & Mahadevappa 
2010b) together with significant reduction in physical effort of walking (Laufer, 
Hausdorff & Ring 2009; Sabut, Sikdar, Mondal, Kumar & Mahadevappa 2010a). 
Thus, the results of this study confirm previous findings. 
5.2.3 Changes in activity and participation 
Because of the nature of this study – a single case study, the most common measure 
of activity, the walking speed over course of 10m or interval of 6 min. (van der Linden 
& Mercer 2017), was not assessed as it would not provide any relevant data. Instead, 
the researchers assessed participant’s mobility in transfers, gait, and balance (not as a 
measure of community mobility) by weakly RMI questionnaire, specifically devel-
oped and validated in individuals post stroke (Chen, Hsieh, Sing, Liaw, Chen & Lin 
2007; Forlander & Bohannon 1999), so that any deterioration or improvement in par-
ticipant’s condition could be detected timely. However, no functional deterioration or 
improvement was detected over the course of the 6-week intervention. As for possible 
improvement, the intervention was probably too short to observe any changes as the 
participant already reached a high score prior onset of the intervention. 
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On contrary, the generic health status questionnaire (EQ-5D) as well as feedback in 
Modified Outpatient Quality of Service Survey showed clear improvements in partic-
ipant’s self-perception of health and participation. The one aspect, the participant 
stressed during few last sessions, was improvement in his gait pattern. This improve-
ment (as described in detail in section 5.2.2) helped him during shop visits as he felt 
much more relaxed, could walk around with greater confidence and comfort. The par-
ticipant was very surprised and pleased as he did not expect any change that could 
occur in such a short time.  
 
Nevertheless, positive significant changes in quality of life, as assessed by SF-36 ques-
tionnaire, were reported by Fernandes et al. (Fernandes, Carvalho & Prado 2006) only 
after 7 weeks of FES-based intervention targeting CPN and tibialis anterior. Similarly, 
Swigchem et al. (van Swigchem, Vloothuis, den Boer, Weerdesteyn & Geurts 2010) 
reported that the participants (chronic phase) were more satisfied with the use of FES-
orhosis (Bioness L300) than with standard AFO regarding walking effort and stability, 
quality of gait pattern and walked distance after only 8 weeks of their study. Therefore, 
it may be that huge changes in participation, from participants’ self-perspective, can 
be reached even in chronic stroke population and after relatively short-term therapy.  
5.2.4 Adverse events addressed 
As mentioned earlier, to date, the description of adverse events occurring during inter-
ventions remains underreported. Therefore, one focus of this study was to record any 
possible difficulties or health issues that arise during the course of this intervention to 
provide overall picture about complications clinician may face during commencement 
of this type of therapy.  
 
The adverse effects, constantly occurring during the intervention, were related to a 
minor skin irritation/redness that disappeared within few hours post treatment. This is 
a very common consequence of electricity applied on skins via self-adhesive elec-
trodes and reported by various authors (Bethoux et al. 2015, 2014; Street, Swain & 
Taylor 2017; Taylor, Humphreys & Swain 2013). Another mild adverse effect was 
once reported stiffness of the whole leg that occurred during the following day after 
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second session of week 6. Because of this, the researchers allowed the participant 
longer recovery time between consequent therapy sessions. As the effect diminished 
within two days, it was probably only a delayed onset of muscle soreness (DOMS) that 
may occur after increasing of training time or intensity and decreasing of the training 
load is the recommended approach to quickly alleviate the DOMS symptoms (Cheung, 
Hume & Maxwell 2003). Although, researchers did not alter the stimulation intensity, 
it may be that the participant was overloaded due to a cumulative training load as he 
actively visited gym 4 times per week throughout the intervention. Nevertheless, none 
of these reported effects was serious enough to prohibit continuation of the study. 
 
The other adverse events were related to technical issues with triggering of the electri-
cal stimulation and skin conductivity. Specifically, researchers had to solve technical 
problem with a footswitch placed under the first metacarpal that wasn’t sufficiently 
pressed during walking (due to elevated first metacarpal in comparison to other foot 
segments) and consequently not triggering stimulation of plantar flexors at the terminal 
and pre-swing phase of participant’s gait. This was solved by adding paper padding 
between the participants foot and the footswitch to guarantee proper contact of the 
footswitch with shoe insole. Further, the poor skin conductivity was solved by proper 
cleaning of the skin surfaces under electrodes and use of moisturizing cream. None of 
these issues, however, required long interruption of the therapy and were successfully 
handled during the sessions (Appendix 6). 
5.3 Limitations 
There are, however, few issues worth discussion. First, the literature review part of 
this study was only based on search of one database (PubMed). Thus, identified articles 
and the abstracted data might not be the proper representation of the current 
knowledge. Second, the nature of the literature review (systematized review) may have 
been a cause of a bias in the literature search and data abstraction by itself as all deci-
sion-making concerning data inclusion and data evaluation was purely done by the 
author without any correcting input from another person. Third, the presented inter-
vention is only a case study. Therefore, presented outcomes, should be interpreted with 
caution and can’t be generalized on whole stroke population. And lastly, the study 
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participant was an individual at chronic stage of the disease without any comorbidities 
or requirements for special therapy. Thus, the therapy could focus only on retraining 
of gait pattern without a need to consider any other health related issues. 
6 CONCLUSION 
The overall aim of this thesis is to introduce the FES for neurorehabilitation in Finland. 
While, the future is hardly predictable, and the author cannot enforce the use of this 
approach in clinical practice, this thesis summarizes and provides all necessary 
knowledge that one needs for clinical application of multi-channel FES in gait reha-
bilitation. In addition, this thesis presents a successful commencement of a case study 
showing that the participant was very satisfied with study progress and outcomes. 
Therefore, the author hopes, that this work provides enough information to encourage 
physiotherapists in Finland and shows them that such a rehabilitation approach can be 
also used in relatively low-cost settings. 
7 FUTURE PROSPECTS 
While everyone in neurorehabilitation field has heard of electrical stimulation, and the 
FES-based therapy is recommended in many national guidelines (Teasell et al. 2020; 
Veerbeek et al. 2014a; Winstein et al. 2016) there is still a common fear of electricity 
among physiotherapists that limits the use of such a rehabilitation approach in clinical 
practice (Auchstaetter et al. 2016). While the author hopes that this study can be used 
as a example for those that are interested and just do not know how to proceed, future 
studies should focus on investigation of areas of this therapy that are not yet well de-
scribed. This includes (i) the benefits of 2 or more stimulating channels for gait training 
(stimulation patterns which are closer to normal gait patterns in able-bodied popula-
tion), (ii) the orthotic and training effects of FES (whether the FES can be used to 
retraining weakened muscles or needs to be used only as an orthotic device), (iii) the 
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benefits of FES training in walking on uneven surfaces or surfaces with obstacles com-
pared with UFO, (iv) the effect on body functions as ankle dorsiflexion, reduction of 
spasticity or knee hyperextension, (v) the kinematic of walking in 3D to clearly show 
the changes in gait pattern (e.g., describing changes in body limping, hip hiking, leg 
circumduction, hip and knee flexion or ankle dorsiflexion), (vi) the possible reduction 
of fall incidents (as measured prior and after the intervention), and especially (vii) the 
cost/time effectiveness of this treatment approach. (van der Linden & Mercer 2017.) 
Only by providing clear answers and evidence depicting benefits of this rehabilitation 
approach, one can achieve its wide spreading among physiotherapists. Thus, the next 
step for future research is to organize a larger scale study in clinical setting as hospital 
or rehabilitation clinic to address one or all above mentioned issues. 
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disorders (e.g., stroke), and consequently their quality of life. As the population is getting older (number 
of stroke survivors is increasing), the incorporation of FES-based therapies may improve and speed up 
individuals’ recovery.  
Nevertheless, the use of neuromuscular stimulation among physiotherapists and especially in task-
oriented therapies is still low, mainly due to a lack of training, time and equipment. Therefore, this study 
aims at introduction and barriers eradication of the FES and specifically the FES-walking therapeutic 
approach in clinical setting in Finland. 
Specifically, the project will evaluate 1) participants safety, 2) adherence to agreed mode of treatment, 
and 3) engagement of an individual taking part in this uncommon therapy involving electrical stimulation. 
Grounds for requesting ethical review: The proposed research involves use of electrical stimulation 
applied to the participants muscle through surface self-adhesive stimulation electrodes that may 
potentially affect the safety of study participant. 
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BACKGROUND 
Today, the advances in acute medical management of stroke are changing the neurological population. 
The percentage of individuals that suffered stroke and survived the first month has increase to more than 
85% (Meretoja et al., 2011). The activity-dependent plasticity of the neural pathways, once thought to be 
unresponsive and incapable of recovery, serves as one prong of scientific evidence challenging the 
assumptions of current clinical practice (Behrman et al., 2006). Activity-based gait therapy, combining 
research on neural plasticity and the role of spinal cord in stepping and standing is applied to Locomotor 
Training (LT). LT works to “awaken” dormant neural pathways by repetitively stimulating the muscles and 
nerves in the lower body. LT is commonly used for stroke survivors and other neurological disorders.  The 
current evidence shows that many stroke survivors have improved their walking after receiving 
therapeutic gait training utilizing various modalities (e.g., body weight-support treadmill (BWST) training, 
robot-based locomotor training) in research programs and rehabilitation clinics internationally, regardless 
of the time elapsed since their disease onset (Mehrholz et al., 2017). Nevertheless, these modalities 
require large amount of men power and/or expensive device as BWST or robot. 
Functional Electrical Stimulation based LT (FES-walking), on the other hand, can be used in conjunction 
with parallel bars or over ground walking; decreasing the need of expensive equipment. Further, the 
recent research has shown that stroke survivors have the capacity to improve voluntary walking function 
following short-term intensive FES therapy (Howlett et al., 2015; Masani and Popovic, 2011). Furthermore, 
the positive effects seemed to be remaining even after therapy cessation (Howlett et al., 2015; Stein et al., 
2015). Therefore, the FES-walking restorative therapy may be possibly used to enhance spinal 
 
KIK-WALK Study – Project plan, Tomas Cervinka  Page 2 of 10 
neuroplasticity, instead of using it as a pure compensatory walking aid (e.g., Bioness or WalkAid) as was 
done in the past (Masani and Popovic, 2011; Popovic and Thrasher, 2004).  
It has been also reported that the FES-walking has positive effects on muscle density, quality of life and 
walking competence (Wilkie et al., 2012), and potential to emulate normal mechanical strains on bone 
during weight-bearing activity. These strains may stimulate bone formation through alterations in muscle 
activity that cannot be achieved with BWST- or robot-based LT training alone (Coupaud et al., 2009).  
Although, the first electrical stimulation for drop foot prevention in stroke survivors was introduced 
already in 1961 (Liberson et al., 1961) and benefits of the FES therapies among stroke survivor population 
compared with conventional exercise programs have been described elsewhere (Howlett et al., 2015; 
Mehrholz et al., 2017). Nevertheless, the use of neuromuscular stimulation among physiotherapists and 
especially in task-oriented therapies (including therapeutic goals as walking, arm function, muscle 
strength, endurance and sensation, prevention of shoulder subluxation, or decrease of spasticity) is still 
low. This is mainly due to a lack of training (inability to use the stimulation with proper setting for execution 
of intended tasks), time and  equipment (Auchstaetter et al., 2016). 
In Canada, this limitation has been recently recognized and recommendations concerning incorporation 
of FES, as one of the key components of activity based therapy, into the main stream health care and 
community programs have been made (Behrman et al., 2017). In addition, the use of FES is in the Canadian 
best practice accreditation guidelines in Stroke rehabilitation. Therefore, this study is proposed to 
introduce the FES in Finland, show potential applications and find out whether potential patients would 
be satisfied with the FES-walking therapeutic approach if used clinically. 
STUDY OBJECTIVES 
The current study aims at feasibility assessment of implementing the FES-walking therapy for stroke 
survivors as the first step of knowledge translation from research to standard clinical practice in Finland. 
The primary objective of this study is to assess feasibility of implementing the FES-walking therapy in 
physiotherapy school setting. Specifically, a construct at a patient and program level will be tested: Safety, 
Adherence and Engagement (Table 1). 
• Safety as defined as the relative freedom from harm. In this study it refers to an absence of harmful 
side effects resulting from the use of FES-walking therapy and may be assessed by adverse events and 
negative change in clinical outcome measures i.e. decreased physical capacity (the Rivermead Mobility 
Index as a functional independence measure). Safety and tolerability of the FES-walking therapy will 
be represented by the degree to which minor adverse effects can be tolerated by the participant. 
Frequency of major adverse events will also be monitored to determine if they occur more frequently. 
• Adherence as defined in this study is the extent to which the participant continues the agreed-upon 
mode of treatment, in this case the parameters of the FES-walking therapy under limited direction 
when faced with conflicting demands (i.e. attendance – 3 days/week).  In the case of this study we will 
monitor frequency and duration of training sessions attended.   
• Engagement, as defined in this study, is the emotional and intellectual involvement in the FES-walking 
therapy. For the patients we will use modification of the existing Patient Quality of Services Survey 
(Appendix 1) 
The secondary objective of this study is to evaluate self-reported quality of life (EQ-5D).  
Refer to the anticipated schedule and data collection section for list of outcome measures and collection 
time points. 
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Table 1: Summary of features collected for assessment of FES-walking implementation feasibility 
Criteria Safety Adherence Engagement 
Provider • # Injuries during 
FES-walking 
• # Consistency of 
trainer/participant alignment 
• Training sessions 
attended 
• Issues addressed 
Participants • # Minor/Major 
events documented 
• # FES-walking sessions 
attended 
• # of discharges for FES-walking 
• # of withdrawals 
• Out-patient Quality 
of Services Survey  
 
RATIONALE FOR FES-WALKING 
The FES-walking has a potential to improve walking competence of stroke survivors, and consequently 
their quality of life (Wilkie et al., 2012). As the population is getting older and number of stroke survivors 
is increasing, the incorporation of FES-based therapies may improve and speed up individuals’ recovery 
(Howlett et al., 2015; Stein et al., 2015). This will result in shorter hospitalization times and improved self-
ambulatory and -caring in individual’s own home environment. Further, this therapy (i) can also ease the 
burden on required manpower during rehabilitation process – the amount of involved personnel 
decreases from 3-4 involved in conventional BWST-LT to 1-2 depending on stage of participant progress, 
(ii) can be used either in combination with treadmill, parallel bars or over-ground walking, (iii) has a 
potential to improve walking competence and consequently quality of life after only a short term intensive 
therapy (Stein et al., 2015, 2010), and (iv) is low costs compared with use of robots (20-fold) enabling its 
use among small rehabilitation clinics with limited budget. Consequently, incorporation of FES-based 
therapy may result in enormous savings in health and social care costs. 
SITE OF RESEARCH 
The proposed study will be undertaken at the premises of the Satakunta University of Applied Science 
(SAMK, www.samk.fi) that include needed equipment, the body weight-supported treadmill, weight-
supported over ground walking and/or parallel bars, for conduction of this study. 
STUDY DESIGN 
Study population 
The proposed study is a case study that will provide information whether it is feasible to utilize FES-walking 
therapy as a standard therapeutic tool in clinical practice. The sample size of 1 participating individual is 
primarily based on feasibility aspects of the bachelor level of this study. 
Potential participants will be identified based on discussion with local stroke community (Aivoliitto). The 
participation in this case study will be offered based on the following selection criteria to ensure that the 
participant has a potential to benefit from the program and that has the capacity to participate fully in the 
sessions.  
Inclusion Criteria: 
• Age ≥ 18 years 
• Medically stable condition 
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• Walking independently either with use of assistive devices or with speed < 0.5 m/s (preclusion of 
being community walker) during a 2-minute walking test. 
• Willingness and possibility to participate in FES-walking therapy 
• Responsiveness to electrical stimulation 
• Proximity to SAMK for realistic access 
• Access to reliable transportation 
• First stroke of cerebrovascular origin with hemiplegia, at least 3 months in duration  
• PNS without evidence of uncontrollable knee hyperextension 
Exclusion Criteria: 
• Bilateral stroke 
• Tendon lengthening surgery in the last 6 months. If greater than 6 months, require surgeon's approval 
• Contraindications to FES (cardiac pacemakers, skin scratches or grade 2 or 3 pressure ulcers at 
potential electrode sites, denervation of targeted muscles) 
• Grade 4 Pressure ulcers anywhere on the lower extremities 
• Uncontrolled Hypertension or symptoms of orthostatic hypotension when standing for 15 minutes 
• Subjects with a history of cardiovascular disease, must obtain medical clearance from their primary 
care physician before inclusion 
• Amyotrophic Lateral Sclerosis or lower motor neuron disorders 
• Dependent on ventilator or unable to voluntarily extend head 
• Painful musculoskeletal dysfunction (e.g., knee deformity) or unhealed fractures 
• Fixed muscle contracture 
• Sensory or motor peripheral neuropathy 
• Unable to follow/understand verbal commands 
• Pregnancy 
• Psychological disorders 
• Uncontrolled seizure disorder 
• Illegal drug use  
• MRSA or other Infectious Diseases requiring contact droplet precautions 
• Active oncology diagnosis 
FES-walking therapy 
FES-walking therapy will be performed on a BWTS with harness system for safety reasons, taking seated 
breaks when desired. The body weight support will be set such that it is sufficient to assist the participant 
to achieve standing without knees buckling. As the therapy progresses, the amount of body weight support 
will decrease with the goal of achieving no support or assistance. 
Depending on the muscle weakness in lower extremities (number of muscle groups with score of 3 or less 
in manual muscle testing), FES will be delivered using up to two 2-channel transcutaneous electric 
stimulators using surface self-adhesive stimulation electrodes. The two stimulators will work 
independently, not being synchronized. The gait sequence of a designated leg will be manually triggered 
using a footswitch or push button, depending on suitability for the participant. Typically, the therapist 
activates the push button shortly after heel-off but before the toe-off phase of the gait cycle. However, in 
cases where a subject has a good balance and control, they will be given the option to control the 
stimulation by themselves.  
The electrodes of the FES stimulator will be placed on the subject’s skin at the motor points above the 
nerves corresponding to the muscles targeted with FES or the nerve itself (peroneal nerve for foot drop 
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stimulation). Electrode size will vary according to size of muscle that needs to be activated: quadriceps 
(electrode size, 5 x 10 cm), hamstrings (electrode size, 5 x 10 cm), tibialis anterior/peroneal nerve 
(electrode size, 2.5 x 2.5 cm) and gastrocnemius (electrode size, 2.5 x 2.5 cm). The stimulation will use 
balanced, biphasic, and current regulated pulses. 
The stimulation parameters will be individually tailored to guarantee the most optimal setting, pulse 
amplitudes will range from 8 – 125 mA, pulse durations from 0 – 400 μs, and frequencies from 20 – 50 Hz. 
Pulse-width modulation will be used to regulate temporal activity of the muscle contraction, the pulse 
amplitude to regulate the strength of the participant’s muscle contraction. The participants will be 
encouraged to produce the intended movement voluntarily in every step. However, if not successful, the 
movement will be triggered by the FES stimulator. In case of a footswitch, the stimulation will be 
automatically triggered with a delay after heel-off to promote participant’s own muscle activation. 
Implementation 
The physiotherapy student (Tomas Cervinka), based on discussion with local stroke community, will inform 
the leading physiotherapist (Maija Kangasperko, SAMK) of an individual who meets the pre-screening 
(inclusion) criteria for the study. The leading physiotherapist or physiotherapy student together with 
leading physiotherapist will inform potential participants of the study, explain the nature of the study, 
along with the purpose, methods and design, anticipated benefits and anticipated risks involved with the 
study and answer any related questions, and obtain written informed consent if potential participant 
expresses his/her interest to undergo this study. 
All potential participants will be screened by the leading physiotherapist for feasibility. Once deemed 
eligible participant will be offered a start date and time to begin participation. The eligible participant will 
receive a battery of initial assessments (the Rivermead Mobility Index and EQ-5D quality of life 
questionnaire) by the physiotherapy student prior to initiation of the therapy. The participant will receive 
15 sessions each involving up to 45 minutes of FES stimulation. Participant will attend therapy 3 times per 
week, 5 weeks in total. In the case of constant muscle fatigue, a frequency of 2 sessions per week may be 
used if deemed appropriate by the leading physiotherapist or the physiotherapy student. Re-assessment 
of participant’s performance (Rivermead Mobility Index) will be done on weekly basis, when there is a 
significant change in participant’s conditions or after 15 sessions as per discharge criteria (Appendix 2). 
Based on an initial gait evaluation done by the physiotherapy student under supervision of leading 
physiotherapist, it will be determined whether the participant has a leg that scores 4 or greater on knee 
flexion/extension, ankle dorsiflexion and plantar flexion in the Manual Muscle Test. If so, the FES 
stimulation will be only applied to the weak muscles.  
During the first three to four sessions, participant undergoes a muscle strengthening (conditioning) 
protocol consisting of stimulation applied to the weak muscles in 20-s duty cycles (e.g., 10 s extensors on 
and flexors off followed by 10 s extensors off and flexors on). These exercises will be performed in four 
sets of 5 min with 5-min rests in between. When all targeted muscle will be capable of creating joint 
movement against gravity (i.e., strength of grade 3 or more), the muscle strengthening protocol will be 
terminated and FES-walking therapy will begin. During this muscle conditioning, participant will be seated 
or placed into an overhead harness system (depending on group of stimulated muscles) to prevent 
accidental falls due to unexpected reactions during first stimulations. 
The FES-walking therapy will be performed on a treadmill with an overhead harness that is attached to 
cables and pulleys so that a constant upward force is applied to the participant while walking. The harness 
will be worn on the treadmill at all times for safety. Overground walking with harness or parallel bars may 
be used as a subsequent step of the therapy, if participant’s performance allows it (based on assessment 
of the leading physiotherapist). The participant will receive the FES-walking therapy for at least 15–30 min 
 
KIK-WALK Study – Project plan, Tomas Cervinka  Page 6 of 10 
per session, taking seated breaks when desired. The body weight support will be set such that it is sufficient 
to assist the participant to achieve standing without knees buckling. As the therapy progresses, the amount 
of body weight support will decrease with the goal of achieving no support or assistance. The treadmill 
speed will be selected by attending physiotherapy student with input from the subject. During therapy, 
manual assistance will be applied to the subject’s lower extremities and/or lower back when needed to 
facilitate normal gait. The leading physiotherapist will be present during all assessments and first training 
session to guarantee the safety of the participant. Further, the leading physiotherapist will have a detailed 
schedule of the intervention and will visit the sessions regularly on a weekly basis or when requested by 
the physiotherapy student or the participant. 
ANTICIPATED SCHEDULE AND DATA COLLECTION 
The estimated time to complete the study presented in this research proposal is 8 months. The study time 
is divided to 3 periods (preparation, intervention and data analysis). Even though the objectives are 
challenging, the unique applicant’s knowledge, the applicant acquired during PhD, post-doctoral and 
physiotherapy studies as well as presence of an experience physiotherapist with over 30 years of clinical 
practice and the straight forward nature of the research plan makes the schedule realistic. 
The first stage (preparation part) of the study will begin in November 2019 and last until January 2020. 
During this phase, all research and ethical permits will be obtained, recruitment of potential participants 
will begin and study place at the SAMK will be prepared for conduction of the second (intervention) stage 
of this study. All the preparations will be done by the physiotherapy student (Tomas Cervinka) under direct 
supervision of the leading physiotherapist (Maija Kangasperko). 
During this process, the physiotherapy student with supervising leading physiotherapist will assess 
potential participants in face-to-face interview and 2-minute walking test according to inclusion and 
exclusion criteria. The interview and test results will be recorded on a checklist forms (Appendix 3 and 4). 
If an individual meets all the inclusion criteria, potential participant will be provided additional information 
concerning the study and offered to sign a consent form to continue the progress. The potential participant 
will be also informed that he/she can withdraw from the study at any point without giving any reason. 
If the potential participant agrees to participate in the study, the he/she will receive an identification 
numerical code (starting by 001) that will be used on all following testing documents, questionnaires and 
study results. As the documents (inclusion/exclusion criteria check list and consent form) contain 
participant’s name, given identification numerical code and telephone number, they will be stored in a 
separate envelope in a locked cabinet at the SAMK’s office of the leading physiotherapist to prevent any 
possible identification of study participating person by any unauthorized person. If an individual doesn’t 
meet all the inclusion criteria or will not present his/her interest in undergoing the study, the checklist 
documents will be shredded and disposed.  
The consenting participant will then undergo a face-to-face physiotherapy assessment to evaluate his/her 
skin integrity, passive range of motion in hips, knees and ankles, and muscle strength of gluteus maximus, 
quadriceps, hamstring, tibialis anterior and calf muscles by manual muscle testing. These tests will be 
performed by the leading physiotherapist or the physiotherapy student under direct supervision of the 
leading physiotherapist to guarantee individual’s safety during the locomotion triggered by FES. The 
results of these test will be recorded on a written form (Appendix 5).  
If the consenting participant will pass the safety testing and will be still willing to continue the study, he/she 
will be offered a start day of the study, the form containing results of the physical assessment will be 
stored in an envelope in a locked cabinet at the SAMK’s office of the leading physiotherapist, and 
recruitment process will be terminated. If an individual doesn’t pass the safety criteria or will not present 
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his/her interest in undergoing the study, the checklist document will be shredded and disposed, and 
recruitment process will continue. 
The second stage (intervention part) of the study will begin on January 20th, 2020 and last until February 
21st, 2020. The intervention will take place at the SAMK premises. The starting date may be slightly 
advanced or postponed based on participants needs. During this phase study participants will undergo 
muscle conditioning program (3-4 sessions) followed by the FES-walking therapy for 4 weeks with 3 
sessions per week. 
1. During the baseline visit on January 20th, 2020, the physiotherapy student (under supervision of the 
leading physiotherapist) will administer following self-reported questionnaires (paper version) to the 
study participant prior onset the actual intervention: 
a. Self-reported quality of life (EQ-5D, Appendix 6) 
b. Rivermead Mobility Index (RMI, Appendix 7) 
In addition, the physiotherapy student will record participant’s age, sex and duration of the disease. 
No other personal details will be recorded. 
2. During the intervention participant will be asked to keep a self-administered diary and record any 
minor/major adverse event that occurred. Investigators (Tomas Cervinka and Maija Kangasperko) will 
follow-up with these recording at the beginning of every therapy session and record the events on a 
paper form (Appendix 8). Further, investigators will use the same form to record injuries during 
therapy and all issues that appeared during the therapy and how they were addressed. In addition, 
investigators will record on a paper form (Appendix 9) the number of sessions (frequency) and 
duration of training sessions attended, and ask the participant to fill the RMI on weekly basis. 
3. After the therapy cessation, the same questionnaires (EQ-5D and RMI) as during the baseline visit will 
be administered. In addition, a written form for self-reported survey of service quality will be 
administered (Quality of Services Survey - Appendix 1) and collected by investigators. 
 
Table 2: Summary of timeline of administered questionnaires and data collection during intervention 
Week Session EQ-5D RMI 
Adverse event 
reporting 
Therapy 
adherence 
Quality of Service 
Survey 
Collected 
by 
1 
Baseline X X  X  TC or MK 
2   X X  TC or MK 
3   X X  TC or MK 
2 
4  X X X  TC or MK 
5   X X  TC or MK 
6   X X  TC or MK 
3 
7  X X X  TC or MK 
8   X X  TC or MK 
9   X X  TC or MK 
4 
10  X X X  TC or MK 
11   X X  TC or MK 
12   X X  TC or MK 
5 
13  X X X  TC or MK 
14   X X  TC or MK 
Follow up X X X X X TC or MK 
All the questionnaires and data recording will be done by the leading physiotherapist (MK) or by the physiotherapy student (TC) under direct 
supervision of the leading physiotherapist.  
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The third stage (data analysis part) of the study will begin in June 2020 and last until August 2020. During 
this phase all collected (de-identified) data will be processed by physiotherapy student (Tomas Cervinka) 
at the Satakunta University of Applied science and transferred to an electronic form that will be stored on 
a private OneDrive school account of Tomas Cervinka. The identifiable forms (inclusion/exclusion criteria) 
and consent form will remain safely stored in a locked cabinet at the SAMK’s office of the leading 
physiotherapist. After that, Tomas Cervinka will analyze and evaluate/interpret the data at his private 
computer at his home. In addition, a bachelor thesis will be written with description of study results. 
Please, see details concerning data management in separated data management plan. 
RISK ANALYSIS 
 
Strengths 
• Implementation of the study protocol is evidence-
based 
• Experience with use of FES in neurological 
rehabilitation 
• Experienced physiotherapist able to recognize who 
can benefit from the therapy and any possible 
threats to the participant 
• Dedicated area at SAMK with all necessary 
equipment for the research 
• Medically trained personal available at SAMK 
facilities 
• Use of novel therapeutic approach that is not 
commonly available at clinical settings.  
• No collection of identifiable data with exception of 
age, sex and duration of disease 
 
Weaknesses 
• Lack of financial support to cover participant’s 
expenses (e.g., transportation) 
• Physiotherapy school setting, results may not be 
directly applicable for clinical settings 
• Novel therapeutic approach that is unknown to 
majority of possible participants  
• Fear of electricity (electricity-based stimulation) 
• Use of electrode system with wires that need to be 
taped to the participants body during the 
locomotion 
• Possible glue (electrodes) induced skin reactions 
• Possible negative effect of the electrical current on 
participant’s skin 
• No direct reach of inner-hospital first aid response 
unit 
• Physiotherapy school setting, an individual can be 
recognized at the premises during the study 
duration 
• No dedicated research office of the leading 
physiotherapist for data storage (open office) 
Opportunities 
• Improved quality of life of the participant 
• Gaining proved intervention protocol that can be 
re-usable in ongoing or future research projects at 
SAMK 
• Increase national visibility of the faculty with 
respect to educational research 
• Possible change of clinical practice (therapeutic 
strategies) when dealing with stroke patients -> 
with use of FES, patients can stand up and 
rehabilitate as soon as medically stable 
• If knowledge spreads nationwide, possible 
improvements in stroke survivors’ recovery (e.g., 
decreased spasticity, increased muscle strength 
and mobility) 
Threats 
• Not being able to find and appropriate participant 
that meets all the inclusion criteria, can benefit 
from the study and can undergo the intervention 
safely 
• Having only one participant that may not finish the 
study due to health, personal reasons etc. 
• Having only one participant, any illness or 
unexpected life situations can confound the 
adherence data 
• Equipment failure 
• Limited time window to perform the intervention 
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APPLICABILITY OF THE RESULTS AND FUTURE DIRECTION 
This is a pilot study designed to prove the feasibility/usability of implementing FES-walking therapy in 
everyday physiotherapy practice. While it is only a short-term intervention, it will also provide a useful 
information about participants’ interest to undergo this type of unconventional therapy and whether any 
adverse events occur. 
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Keep Improving Kinematics in Walking (KIK-Walk): Functional 
Electric Stimulation Based Locomotor Training 
 
 
Primary Investigator  Tomas Cervinka, Sc.D. (tech), MSc. (Biomed Eng), Physiotherapy student (SAMK) 
Supervisors  Maija Kankasperko, PT (Am) MSc., Senior Lecture, Degree Program Coordinator, 
Satakunnan University of Applied Science, Pori, Finland. 
 
BACKGROUND 
Today, the advances in acute medical management of stroke are changing the neurological population. 
The percentage of individuals that suffered stroke and survived the first month has increase to more than 
85%. The activity-dependent plasticity of the neural pathways, once thought to be unresponsive and 
incapable of recovery, serves as one prong of scientific evidence challenging the assumptions of current 
clinical practice. Activity-based gait therapy, combining research on neural plasticity and the role of spinal 
cord in stepping and standing is applied to Locomotor Training (LT). LT works to “awaken” dormant neural 
pathways by repetitively stimulating the muscles and nerves in the lower body. LT is commonly used for 
stroke survivors and other neurological disorders. The current evidence shows that stroke survivors have 
improved their walking after receiving therapeutic gait training utilizing various modalities (e.g., body 
weight-support treadmill (BWST) training, robot-based locomotor training) in research programs and 
rehabilitation clinics internationally, regardless of the time elapsed since their disease onset. Nevertheless, 
these modalities require large amount of men power and/or expensive device as BWST or robot. 
Functional Electrical Stimulation based LT (FES-walking), on the other hand, can be used in conjunction 
with parallel bars or over ground walking; decreasing the need of expensive equipment. Further, the 
recent research has shown that stroke survivors have the capacity to improve voluntary walking function 
following short-term intensive FES therapy. Furthermore, the positive effects seemed to be remaining 
even after therapy cessation.  
Although, the first electrical stimulation for drop foot prevention in stroke survivors was introduced 
already in 1961 and the benefits of the FES therapies among stroke survivor population compared with 
conventional exercise programs have been described elsewhere. Nevertheless, the use of neuromuscular 
stimulation among physiotherapists and especially in task-oriented therapies is still low, mainly due to lack 
of training.  Therefore, this study is proposed to introduce the FES in Finland, show potential applications 
and find out whether potential patients would be satisfied with the FES-walking therapeutic approach if 
used clinically. 
STUDY OBJECTIVES 
This study aims at feasibility assessment of implementing the FES-walking therapy for stroke survivors as 
the first step of knowledge translation from research to standard clinical practice in Finland. Specifically, a 
construct at a patient and program level will be tested: Safety, Adherence and Engagement. In addition, 
self-reported quality of life will be evaluated. 
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RATIONALE FOR FES-WALKING 
The FES-walking has a potential to improve walking competence of stroke survivors, and consequently 
their quality of life. As the population is getting older and number of stroke survivors is increasing, the 
incorporation of FES-based therapies may improve and speed up individuals’ recovery. This will result in 
shorter hospitalization times and improved self-ambulatory and -caring in individual’s own home 
environment. Further, this therapy (i) can also ease the burden on required manpower during 
rehabilitation process – the amount of involved personnel decreases from 3-4 involved in conventional LT 
to 1-2 depending on stage of participant progress, (ii) can be used either in combination with treadmill, 
parallel bars or over-ground walking, (iii) has a potential to improve walking competence and consequently 
quality of life after only a short term intensive therapy, and (iv) is low costs compared with use of robots 
(20-fold) enabling its use among small rehabilitation clinics with limited budget. Consequently, 
incorporation of FES-based therapy may result in enormous savings in health and social care costs. 
METHODOLOGY 
The proposed study will be undertaken at the premises of the Satakunta University of Applied Science 
(SAMK, www.samk.fi) that include needed equipment, the body weight-supported treadmill, weight-
supported over ground walking and/or parallel bars, for conduction of this study. 
Potential participants (n = 1) will be identified based on discussion with local stroke community (Aivoliitto). 
The participation in this case study will be offered based on strict selection criteria to ensure that the 
participant has a potential to benefit from the program and has the capacity to fully participate. 
The eligible participant receives a battery of initial assessments (Functional Independence Measure and 
quality of life questionnaire) prior to initiation of FES-walking therapy. The participant will receive 15 
sessions each involving up to 45 minutes of FES stimulation. Participant will attend therapy 3 times per 
week, 5 weeks in total. Re-assessment of participant’s performance will be done when there is a significant 
change in participant’s conditions and/or after 15 sessions.  
Based on an initial gait evaluation, it will be determined whether the participant has a leg that scores 4 or 
greater on knee flexion/extension, ankle dorsiflexion and plantar flexion in the Manual Muscle Test. If so, 
the FES stimulation will be only applied to the weak muscles. FES will be delivered using transcutaneous 
electric stimulators via surface self-adhesive stimulation electrodes. During the first three to four sessions, 
participant undergoes a muscle strengthening (conditioning) protocol consisting of stimulation applied to 
the weak muscles in 20-s duty cycles (e.g., 10 s extensors on and flexors off followed by 10 s extensors off 
and flexors on). These exercises will be performed in four sets of 5 min with 5-min rests in between. When 
all targeted muscle will be capable of creating joint movement against gravity (i.e., strength of grade 3 or 
more), the muscle strengthening protocol will be terminated and FES-walking therapy will begin. 
ANTICIPATED SCHEDULE 
The estimated time to complete the study presented in this research proposal is 8 months. The study time 
is divided to 3 periods (preparation, intervention and data analysis). The preparation will begin in 
November 2019 and last until January 2020. The intervention part of the study will be initiated in January 
2020 and last until March 2020. The data analysis part will start in June 2020 and last until August 2020.  
Bachelor Research Project Plan - Summary 
 
Tomas Cervinka, Bachelor Research Project Summary 2019-2020 Page 1 of 3 
 
 
Paranna kävelyn kinematiikkaa (engl. KIK Walk): 
Funktionaaliseen sähköstimulaatioon perustuva 
liikkumisharjoittelu 
 
Vastaava tutkija Tomas Cervinka, TkT, fysioterapiaopiskelija (SAMK) 
Ohjaaja Maija Kangasperko, (Amk), lehtori, koulutusohjelmakoordinaattori, Satakunnan 
ammattikorkeakoulu, Pori, Suomi. 
 
TAUSTAA 
Aivoinfarktien akuutissa lääkinnällisessä hoidossa vaikuttaa nykypäivän neurologisista oireista kärsivän 
väestön kokonaistilanteeseen. Aivoinfarktista henkiin jääneiden osuus on ensimmäisen kuukauden jälkeen 
noussut yli 85%:in. Hermoreiden aktiivisuusriippuvaisen plastisuuden on aiemmin ajateltu olevan 
kykenemätön palautumaan vakavista haittatapahtumista. Aivoinfarktista toipuminen tarjoavat kuitenkin 
yhden uuden tieteellisen suunnan ja se haastaa nykyiset kliiniset toimintatavat. Aktiivisuuteen perustuvaa 
askel-terapiaa, joka yhdistää tutkimustietoa neuroplastisuudesta eli hermostollisesta joustavuudesta sekä 
selkäytimen roolista kävelyssä ja seisomisessa, sovelletaan lokomotorisessa harjoittelussa (LT, engl. 
Locomotor Training). Lokomotorisessa harjoittelussa alavartalon lihasten ja hermojen toistuva stimulointi 
toimii uinuvien hermoväylien ”herättäjänä”. Lokomotorista harjoittelua on tavallisesti käytetty 
aivohalvauksen tai muun neurologisen toimintahäiriön omaavilla henkilöillä. Tämän hetken tieteellinen 
näyttö kertoo, että useat edellä mainittuun ryhmään kuuluvista potilaista, jotka ovat saaneet terapeuttista 
askelhoitoa, ovat parantaneet kävelykykyään riippumatta siitä, kuinka kauan aikaa on kulunut heidän 
sairautensa alkamisesta. Hoitoa on toteutettu tutkimusohjelmissa ja kuntoutusklinikoilla, joissa on 
hyödynnetty moninaisia työvoimaintensiivisiä tai kalliita laitteita vaativia kuntoutusmuotoja kuten 
kehonpaino-tuettua juoksumattoharjoittelua (BWST, engl. body weight-support treadmill) tai robotiikkaan 
perustuvaa liikeharjoittelua. 
Toisaalta hoitomuotona voidaan käyttää toiminnalliseen sähköstimulaatioon perustuvaa lokomotorista 
harjoittelua (FES-kävely, engl. Functional Electrical Stimulation-walking) yhdessä nojapuu- tai ”ympäriinsä” 
kävelyn kanssa, jolloin kalliiden laitteiden tarve vähentyy. Tämän lisäksi viimeaikainen tutkimus on 
osoittanut, että aivoinfarktista selvinneillä on kyky parantaa tahdonalaista kävelytoimintoa lyhytaikaisen 
intensiivisen FES-hoidon avulla. Positiiviset vaikutukset näyttivät lisäksi säilyvän myös hoidon päätyttyä. 
Ensimmäinen sähköstimulaatioon perustuva interventio alaraajojen toimintahäiriöiden ennaltaehkäisyyn 
aivoinfarktista selvinneillä esiteltiin jo vuonna 1961. Myös FES-hoidon edut kuvattiin aivoinfarktista 
selvinneillä väestössä tavanomaiseen harjoitusohjelmaan verrattuna jo silloin. Niinpä FES:iin perustuvat 
hoitomuodot ovat joissain maissa, kuten Kanadassa, osa neurologisen kuntoutuksen Käypähoito- 
suositusta. Silti neuromuskulaarisen stimulaation käyttö on yhä fysioterapeuttien ja erityisesti 
toiminnallisten terapioiden joukossa vähäistä johtuen pääasiassa koulutuksen puutteesta. Tämän 
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tutkimuksen tarkoituksena on selvittää toiminnallisen ja sähköstimuloidun kävelyn (FES) 
toteuttamiskelpoisuutta niin että FES terapiaa voisi tulla käyttöön kliinisessä kuntoutuksessa Suomessa. 
TUTKIMUKSEN TAVOITTEET 
Tämän tutkimuksen tavoitteena on arvioida FES-kävelyhoidon soveltuvuutta aivoinfarktista selvinneillä 
henkilöillä Suomessa. Täten tutkimus on ensiaskel laboratiivisen tutkimustiedon siirtämiseksi kliiniseksi 
käytännöksi. Hoitomallia testataan erityisesti potilas- ja ohjelmatasolla. Se tarkoittaa turvallisuuden, 
hoitoon sitoutuneisuuden ja siihen osallistumisen selvittämistä. Lisäksi tutkimuksessa arvioidaan 
yksilöiden itse arvioitua elämänlaatua ja käytetään fyysisen toimintakyvyn mittareita, jotka kuvaavat 
yksilön liikkumiskykyä. 
FES-KÄVELYN PERUSTEET 
FES-kävelyn avulla on mahdollista parantaa kävelykykyä ihmisille joita selvinnyt aivoinfarktista, ja tällä 
tavoin myös kohentaa heidän elämänlaatuaan. Kun väestö Suomessa ikääntyy ja samaan aikaan 
aivohalvauksesta henkiin jääneiden lukumäärä kasvaa, FES-perusteisen hoidon liittäminen muihin 
hoitoihin voi sekä edistää että nopeuttaa yksilöiden parantumista. Tämä puolestaan lyhentää 
sairaalassaolojaksoja ja kohentaa omaehtoista liikkumista sekä mahdollistaa hoivaa kotiympäristössä. 
Tähän liittyen uusi hoito voi i) keventää hoitoresursseihin kohdistuvaa taakkaa kuntoutusprosessin aikana, 
koska tarvittavan hoitohenkilöstön määrä putoaa tavanomaisen lokomotorisen hoidon vaatimasta 3-4 
henkilöstä 1-2 henkilöön kuntoutettavan edistymisestä riippuen. Lisäksi lokomotorinen hoito (ii) voidaan 
yhdistää joko juoksumaton, nojapuiden tai ”ympäriinsä kävelyn” hyödyntämiseen, (iii) se omaa 
potentiaalia edistää kävelykykyä ja sen myötä elämänlaatua jo lyhyen intensiivisen hoitojakson jälkeen ja 
lisäksi (iv) lokomotorinen hoito on edullisempaa kustannuksiltaan, kun sitä verrataan esimerkiksi robottien 
käyttöön (joista syntyy 20- kertaiset kustannukset) ja se mahdollistaa hoidon myös pienillä resursseilla 
toimivilla kuntoutusklinikoilla. Kaiken kaikkiaan FES-perusteisen hoidon liittäminen osaksi potilaiden 
kuntoutusta voi johtaa suuriin säästöihin terveys- ja sosiaalimenoissa. 
MENETELMÄT 
Tutkimus toteutetaan Satakunnan Ammattikorkeakoulussa (SAMK). SAMK tarjoaa BWST valmennuksen 
käyttöön tarvittavat tutkimustilat ja -laitteet. 
Potentiaaliset osallistujat (n = 1) identifioidaan paikallisen aivohalvausyhteisön (Aivoliitto) kanssa. Tarkat 
valintakriteerit täyttäville potilaille, joilla on arvioitu olevan kuntoutusmuodon vaatima toimintakyky ja 
mahdollisuus hyötyä ohjelmasta, tullaan tarjoamaan mahdollisuutta lähteä mukaan tutkimukseen. 
Tutkimukseen soveltuvat osallistujat testataan ennen FES-kävelyhoidon aloittamista lähtötasoarviossa, 
johon kuuluvat Rivermeadin liikkumiskyky -indeksi, sekä kyselyllä tehtävä itsearviointi elämänlaadusta. 
Osallistujille tarjotaan FES-stimulaatiota 15 kertaa 45 minuutin jaksoissa, jotka toteutetaan kolmena 
käyntinä viikossa viiden viikon ajan. Osallistujien suorituskyvyn uudelleenarviot tehdään, jos/kun on 
havaittavissa merkittävä muutos osallistujan tilassa ja/tai intervention lopuksi 15 käynnin jälkeen. 
Alkutilanteen askelluksen perusteella Manual Muscle- testissä määritellään osallistujan alaraajojen 
lihastoiminnalle pistemäärä, joka on joko neljä tai suurempi polven koukistuksessa/ojennuksessa sekä 
nilkan dorsaali- ja plantaarifleksiossa. Näissä tapauksissa FES-stimulaatiota sovelletaan vain heikommille 
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lihaksille. Jos molemmissa jaloissa todetaan yhtäläistä lihasheikkoutta sekä vahvuudessa että toiminnassa, 
FES-stimulaatiota sovelletaan molempiin jalkoihin. FES tapahtuu käyttämällä itsekiinnittyviä 
transkutaanisia (ihoaläpäiseviä) sähköstimulaatioelektrodeja. Ensimmäisten kolmen tai neljän käynnin 
aikana osallistujat saavat lihaksia vahvistavaa hoitoa, jossa stimulaatio kohdistuu heikkoihin lihaksiin 20 
vuoron sykleissä (esim. 10 sekunnin ajan ojentajiin, jolloin koukistajat ovat levossa ja seuraavaksi ojentajat 
ovat levossa, jolloin 10 sekunnin stimulaatio kohdistuu koukistajiin). Nämä harjoitteet tehdään viiden 
minuutin sarjoissa, joissa on vuoroin viisi minuuttia harjoittelua ja viisi minuuttia lepoa. Kun kaikki 
kohdelihakset pystyvät tuottamaan nivelen liikettä vetoa vastaan (esim. voima-asteikolla 3 tai enemmän), 
lihasten vahvistusohjelma päättyy ja FES-hoito voi alkaa.  
TUTKIMUKSEN AIKATAULU  
Tässä suunnitelmassa esitetty kliininen tutkimus on kestoltaan kahdeksan kuukautta. Tutkimusaika on 
jaettu kolmeen jaksoon (valmistelu, interventio ja aineisto-analyysit). Valistelu alkaa lokakuussa 2019 ja 
kestää tamikuun 2020 asti. Intervention alkaa tamikuussa 2020 ja lopuu maaliskuussa 2020. Aineisto-
analyysit alkavat kesäkuussa ja kestävät elokuun 2020 lopuun asti. 
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Patient Information Form 
 
Title of Study Keep Improving Kinematics in Walking (KIK-Walk): Functional Electric Stimulation 
Based Locomotor Training 
Primary Investigator  Dr. Tomas Cervinka, PT student (Am) 
Supervisors  Maija Kankasperko, PT (Am) MSc. 
 
 
This is an observational study of a walking training program involving functional electrical stimulation 
(FES) for stroke survivors. For research purposes, we would like to assess the feasibility of using novel 
therapy for improvement of Your walking competence in physiotherapy school setting. During the study, 
we would like to collect information concerning therapy’s safety and how well You can follow the 
requirements of this training program. In addition, we would like to collect outcome measures related 
to self-reported quality of life and physical functioning (mobility index describing Your ability to stand 
up, walk, walk the stairs etc.). 
 
Introduction 
The brain naturally uses electrical current while communicating with other body parts. When an individual 
wants to move, the brain sends electrical signals through nervous system to activate/contract muscles that 
are needed for the particular movement. In individuals with neurological disorder as stroke, these signals 
may be altered or do not reach the targeted muscles. Therefore, muscles do not contract as needed to 
perform desired movement.  
The FES-based therapy uses an electrical current from an outside source that is directly applied to the skin 
over nerve controlling paralyzed or weakened muscle, or over the bulk of the muscle itself. This external 
stimulation simulates the brain function and causes muscle contractions. These contractions can assist the 
weakened or paralyzed muscles in functional movements as walking. By improving the muscle 
contractions, the FES-based therapy promotes an increase in muscle strength, mobility, and decreasing 
pain and muscle spasticity. Consequently, the FES-based therapy may help to prevent muscle loss and/or 
promote recovery of normal movement functions.  
Risks 
The FES is generally well tolerated and serious medical complications are rare. The most common 
problems with FES are discomfort or pain (“pins and needles” like sensation on skin), skin redness or 
irritation, nausea, light-headedness, or autonomic dysreflexia. The discomfort can range from a mild 
tingling to almost a burning sensation depending on stimulation parameters. Nevertheless, these 
parameters can be easily adjusted to decrease the discomfort in most of the cases. The skin redness may 
be left in places where electrodes were placed on the skin because of glue used on self-adhesive 
electrodes, but this redness usually disappears within an hour. In rare cases, the non-latex hypoallergenic 
electrodes have to be used to solve the problem. 
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Less common risk or rare side effects are skin breakdown, fainting, worsening of muscle spasms, muscle 
and joint injuries (strains or swelling), bone fractures in case of severe osteoporosis, and mild electrical 
burns near electrodes in case of improper use or faulty equipment. In case of signs that similar 
complications should occur, the intervention will be immediately terminated. 
Procedures 
The FES therapy is planned to last 5 weeks with frequency of 3 sessions per week (15 sessions in total). 
Each therapy session will take 60min. to complete and all sessions will be held at SAMK premisses. The 
therapy is divided into two phases. During the phase one, first 3 to 4 sessions, You will undergo a muscle 
strengthening protocol consisting of stimulation applied to the weak muscles. The stimulation will be 
performed in four sets of 5 min (in cycles of 10s with stimulation on and 10s off) with 5-min rests in 
between. This protocol ensures that stimulated muscles can produce sufficient strength for following FES-
based walking therapy. The phase two will consist of 11 to 12 sessions during which You will receive the 
FES-walking therapy on a treadmill with an overhead harness for at least 15–30 min per session, taking 
seated breaks when needed. During the therapy, you will try to initiate the steps on your own at first. If 
your muscles will not contract sufficiently to perform the step movement, the supervising physiotherapist 
or a switch placed into Your shoe will trigger the electrical stimulation that will assist You in performing 
the movement (step). While on the treadmill, You will always wear the harness for safety to prevent falls. 
Overground walking or walking between parallel bars may be used later within the therapy, if Your 
performance allows it. 
Timeline and data collection 
The study is planned to start on January 20th, 2020.  However, in case of time issues, we can slightly 
postpone or advance the study according Your needs. During the first visit, the physiotherapy student 
(under supervision of the leading physiotherapist) will give You two paper self-reported questionnaires, 
related to your life quality and physical functioning, to fill. In addition, You will be asked to provide your 
current age, sex and time post stroke in months/years. After filling the questionnaires, they will be 
collected, and the first therapy session will begin. During the first therapy, a short video (view from knees 
down) of Your walking will be recorded with and without FES stimulation. This video will serve as a baseline 
information for assessing of the walking progress after the cessation of the intervention. Later, the video 
will used for promotion of this approach and for educational purposes, as well as in bachelor thesis of 
Tomas Cervinka. 
During the study, You will be asked to fill the questionnaire related to Your physical functioning on weakly 
basis to follow any possible change in Your condition. In addition, You will be asked to document on daily 
basis and report to us any adverse event (untoward medical occurrence) that will occur during the study 
duration. Adverse events are defined as any change in your medical condition, injury, changes in your skin 
integrity, eczema etc. You will be asked to record everything even if the events may seem to be un-related 
to the therapy. The purpose of this report is to collect information concerning safety and tolerability of 
this intensive therapy. 
During the last session on February 21st, 2020, the second short video, showing the progress/changes in 
Your walking pattern after the 5 weeks of intervention will be recorded. 
After the last session, You will be again asked to fill paper self-reported questionnaires, related to Your life 
quality and physical functioning. In addition, You will be also asked to complete a Quality of Services Survey 
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questionnaire. The purpose of the survey is to learn about your experiences with the FES-walking therapy 
and whether You would be interested to continue with such a therapy during standard rehabilitation. 
The summary of study timeline with specified time points for questionnaire collection, together with 
information who will be collecting/recording the data, is provided in Table 1. 
 
Table 1: Summary of timeline of administered questionnaires and data collection during intervention 
Week Phase Session EQ-5D RMI 
Adverse event 
reporting 
Therapy 
adherence 
Quality of Service 
Survey 
Collected 
by 
1 
1 
1 X X  X  TC or MK 
2   X X  TC or MK 
3   X X  TC or MK 
2 
4  X X X  TC or MK 
2 
5   X X  TC or MK 
6   X X  TC or MK 
3 
7  X X X  TC or MK 
8   X X  TC or MK 
9   X X  TC or MK 
4 
10  X X X  TC or MK 
11   X X  TC or MK 
12   X X  TC or MK 
5 
13  X X X  TC or MK 
14   X X  TC or MK 
15 X X X X X TC or MK 
EQ-5D – quality of life questionnaire, RMI – questionnaire related to physical functioning, Therapy adherence – record of the number of sessions 
and duration of training sessions. All the questionnaires and data recording will be done by the leading physiotherapist (MK) or by the 
physiotherapy student (TC) under direct supervision of the leading physiotherapist.  
Data storage and archiving plan 
After signing the consent form, You will receive a unique identification (ID) number and only this ID will be 
used on all paper forms, questionnaires and videos that will be later collected by investigators Tomas 
Cervinka or Maija Kangasperko during the study. Concerning personal information, only age, sex and time 
post stroke will be recorded in addition to your name and telephone number.  
All collected data, except the videos, will be stored in envelopes in a locked cabinet at the SAMK’s office 
of the leading physiotherapist. However, a key file linking Your information (name and telephone number) 
to the ID together with consent form will be stored separately from the other collected data in a closed 
envelope to prevent Your possible identification by an unauthorized person. The video recordings of Your 
gait (view from knees down) will be stored in personal storage cloud of Tomas Cervinka without Under 
given ID and protected by a password. Data collected during the study will be stored for research purposes 
for 10 years upon completion of the study. 
Confidentiality 
If You participate in this study, it is important to note that a copy of Your signed consent form and the data 
that follows will be stored at the Satakunta University of Applied Science (SAMK). Only Your data related 
to your age and sex, time post stroke, count of adverse events, study adherence and engagement, results 
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of self-reported questionnaires (quality of life, physical functioning, patient quality of service survey) and
video of your gait pattern will be stored in paper and electronically and may be shared outside of the
SAMK. Nevertheless, all research study data collected and stored in Your research file will not be shared
with anyone except with Your consent or as required by law.
All collected personal information (Your name and phone number) will be removed from the collected
data and will be replaced with a number. A list linking the number with your name, together with consent
form, will be kept separately from data collected during the study in an envelope in a locked cabinet of
the leading physiotherapist (Maija Kangasperko). If the results of the study are published, Your name will
not be used and no information that discloses Your identity will be released or published without Your
specific consent to the disclosure.
Nevertheless, we have to inform You that despite of our best intention to not reveal Your name, You may
be noticed at the school premises during your visits and faced with questions related to the reason why
You visit the school premises regularly.
Data ownership and usage rights
By signing the consent form and agreeing to participate in the study, You will give Your permission to use
all collected de-identified data for future analyses and other research purposes. It also means that the
data collected during this study (age and sex, time post stroke, count of adverse events, study adherence
and engagement and results of self-reported questionnaires) may be shared outside of the Satakunta
University of Applied Science with permission from investigators.
Conflict of Interest
Investigators/researchers have an interest in completing this study. However, their interests should not
influence Your decision to participate in this study.
Rights as a Participant
If you volunteer to be in this study, You may withdraw at any time point without giving reason. If You
withdraw from the study, You have the option of removing any or all of Your data from the study, with the
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the physiotherapy student Tomas Cervinka +358 xx xxx xxxx or please call the study supervisors and
leading physiotherapist Maija Kangasperko PT, MSc. +358 xx xxx xxxx.
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KIK-Kävely tutkimus 
Potilaan tiedonantolomake 
 
Tutkimuksen aihe KIK-kävely (Keep Improving Kinematics in Walking): Functional Electric 
Stimulation Based Locomotor Training  
Päätutkija  Tohtori Tomas Cervinka, fysioterapiaopiskelia (AMK) 
Ohjaaja  Maija Kankasperko, fysioterapeutti (AMK), MSc. 
 
 
Tämä on havainnoiva tutkimus uudesta kävelyharjoitusohjelmasta, johon kuuluu toiminnallista 
sähköstimulaatiota (functional electrical stimulation, FES) aivoinfarktista selviytyneille. Tämän 
tutkimuksen tarkoituksena on arvioida terapian soveltuvuutta kävelykyvyn parantamiseen. Tutkimuksen 
aikana keräämme tietoa terapian turvallisuudesta ja osallistujien kyvystä toteuttaa harjoitusohjelmaa. 
Lisäksi haluamme seurata osallistujien omia kokemuksia mahdollisista elämänlaatuun ja fyysiseen 
toimintakykyyn vaikuttavista muutoksista tutkimuksen aikana. 
 
Esittely 
Luonnostaan aivot käyttävät sähkövirtaa kommunikoidessaan muiden kehon osien kanssa. Kun ihminen 
haluaa liikkua, hänen aivonsa lähettävät sähköisiä signaaleja pitkin hermostoa aktivoidakseen/supistaakseen 
lihaksia joita tarvitaan halutun liikkeen suorittamiseen. Yksilöillä, joilla on neurologisia ongelmia (esimerkiksi 
aivoinfarkti), nämä signaalit saattavat muuttua eivätkä välttämättä saavuta kohdelihaksia. Tästä johtuen 
lihakset eivät supistu kuten halutun liikkeen toteuttamiseksi vaadittaisiin.  
 
Toiminnalliseen sähköstimulaatioon (FES) perustuva terapia käyttää ulkoista sähkövirtaa, joka johdetaan joko 
iholle halvaantunutta tai heikentynyttä lihasta säätelevän hermon päälle tai suoraan lihaksen päälle. Tämä 
ulkoinen stimulaatio matkii aivojen lähettämiä signaaleja saaden aikaan lihassupistuksia. Nämä supistukset 
voivat auttaa heikentyneitä tai halvaantuneita lihaksia suorittamaan toiminnallisia liikkeitä, kuten kävelyä. 
Kehittämällä lihassupistuksia FES-terapia edistää lihasvoiman kehittymistä, liikkuvuutta sekä vähentää kipua 
ja lihasspastisuutta. Tästä johtuen FES-terapia voi auttaa ehkäisemään lihaskatoa ja/tai edistää normaalien 
liiketoimintojen palautumista. 
  
Riskit 
Toiminnallinen sähköstimulaatio (FES) on yleensä hyvin siedetty. Yleisimpiä esiintyviä haittavaikutuksia ovat 
ihon punoitus, ärtyminen, kipu/ihon kihelmöinti, pahoinvointi, huimaus sekä autonomisen hermoston 
toimintahäiriöt. Näitä haittoja voidaan vähentää säätämällä iholle johdettavan sähköärsykkeen 
voimakkuutta. Iholle laitettavien elektrodien liimapinta voi aiheuttaa punaisia jälkiä, joka yleensä häviää 
tunnin sisällä elektrodien irrottamisesta. Lateksiallergisille henkilöille käytetään lateksittomia hypoallergisia 
elektrodeja. Harvinaisina vakavampina sivuvaikutuksina voi esiintyä ihon rikkoutumista, lihasten venähdyksiä 
tai lihaskouristuksia sekä nivelturvotusta. Vaikeaa osteoporoosia sairastavalla luunmurtumariski on 
suurentunut. Lievät palovammat elektrodien lähellä niiden vääränlaisen käytön tai viallisten välineiden 
vuoksi ovat mahdollisia. Yllämainittujen oireiden ilmaantuessa terapia keskeytetään välittömästi.  
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Menetelmät 
Terapian on suunniteltu kestävän 5 viikkoa, jonka aikana tapaamisia järjestetään 3 kertaa viikossa (yhteensä 
15 tapaamista). Jokainen fysioterapiakerta kestää 60 minuuttia ja toteutetaan SAMK:in (Satakunnan 
Ammattikorkeakoulu) tiloissa. Fysioterapia jaetaan kahteen osioon: 
 
Ensimmäinen osio 
Ensimmäisillä 3-4 tapaamiskerralla pyritään vahvistamaan heikkoja lihaksia stimuloimalla niitä sähkövirran 
avulla. Tämä stimulaatio tapahtuu neljässä viiden minuutin jaksossa. Yhden jakson aikana lihasta 
stimuloidaan kerralla 10 sekuntia jota seuraa 10 sekunnin lepo. Jaksojen välillä pidetään viiden minuutin 
tauko. Näin varmistetaan että stimuloidut lihakset pystyvät tuottamaan riittävästi voimaa FES-kävelyterapian 
toteuttamiseksi ja voidaan siirtyä fysioterapian toiseen vaiheeseen.  
 
Toinen osio 
Seuraavilla (11-12) tapaamiskerralla terapia toteutetaan juoksumatolla, jossa osallistujalle annetaan FES-
terapiaa. Terapiaa annetaan vähintään 15-30 minuuttia jokaisella tapaamiskerralla pitäen tarvittaessa 
istumataukoja tarvittaessa. Terapian aikana osallistuja yrittää ensin ottaa askelia omatoimisesti. Jos lihakset 
eivät supistu riittävästi askeleiden onnistumiseksi, fysioterapeutti tai kenkään kiinnitetty katkaisija antaa 
lihaksiin sähköstimulaation, joka auttaa askeleen ottamisessa. Juoksumatolla osallistuja on kytkettynä 
yläpuolella oleviin valjaisiin turvallisuussyistä. Terapian edetessä voidaan siirtyä myös rinnakkaisten puomien 
välissä tai lattialla kävelyyn osallistujan suoristuskyvyn sen salliessa. 
 
Aikataulu ja tietojen keräys 
Tutkimuksen on suunniteltu alkavan tammikuun 20.päivä, 2020. Ensimmäisellä tapaamiskerralla teitä 
pyydetään täyttämään 2 kyselylomaketta, joissa on kysymyksiä liittyen elämänlaatuun ja fyysiseen 
toimintakykyyn. Lisäksi teitä pyydetään kertomaan ikänne, sukupuolenne ja aivoinfarktistanne kulunut aika 
kuukausissa/vuosissa. Sekä ensimmäisellä että viimeisellä tapaamiskerralla kävelystänne kuvataan lyhyt 
video (kuvaus polvista alaspäin) alkutilanteen ja terapiahoidon aiheuttaman muutoksen arvioimiseksi. 
Myöhemmin näitä videoita käytetään terapiamuodon esittelemiseksi, opetustarkoituksissa sekä osana 
Tomas Cervinkan opinnäytetyötä.  
 
Tutkimuksen aikana teitä pyydetään täyttämään kysely fyysisestä toimintakyvystänne viikoittain. Lisäksi 
toivomme teidän ilmoittavan meille kaikista vointiinne liittyvistä muutoksista tai oireista, joita ilmenee 
tutkimuksen aikana, vaikka nämä eivät vaikuttaisikaan olevan yhteydessä terapiaan. Tällaisia oireita ovat 
esimerkiksi ihottuma, tapaturmat ja muutokset terveydentilassa. 
 
Viimeisen tapaamisen jälkeen pyydämme teitä jälleen täyttämään kyselyn koskien elämänlaatua ja fyysistä 
toimintakykyä sekä kyselyn saamastanne fysioterapiapalvelusta. Kyselyn tarkoituksena on oppia 
kokemuksistanne FES-terapian aikana sekä mahdollisesta halukkuudestanne jatkaa FES-terapiaa normaalin 
kuntoutuksen ohessa.  
 
Yhteenveto tutkimuksen aikataulusta ja tarkat kyselyiden ajankohdat, sekä tieto siitä, kuka tiedon tulee 
keräämään, löytyy taulukosta 1.  
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Taulukko 1: Yhteenveto kyselyjen jakamis aikataulusta ja tiedon keräämisestä tutkimuksen aikana 
Viik-
ko 
Osio 
Tapaa-
minen 
EQ-5D RMI 
Haitallisten 
tapahtumien 
ilmoitukset 
Terapian 
edistyminen 
Palvelun laatu-
kysely 
Kerääjä 
1 
1 
1 X X  X  TC tai MK 
2   X X  TC tai MK 
3   X X  TC tai MK 
2 
4  X X X  TC tai MK 
2 
5   X X  TC tai MK 
6   X X  TC tai MK 
3 
7  X X X  TC tai MK 
8   X X  TC tai MK 
9   X X  TC tai MK 
4 
10  X X X  TC tai MK 
11   X X  TC tai MK 
12   X X  TC tai MK 
5 
13  X X X  TC tai MK 
14   X X  TC tai MK 
15 X X X X X TC tai MK 
EQ-5D – elämänlaatu-kysely, RMI – fyysinen toimintakyky- kysely, terapian edistyminen – tapaamisten lukumäärä ja sessioiden kesto. Kaikki kyselyt 
ja tiedonkeruu tapahtuvat valvovan fysioterapeutin (MK) tai fysioterapiaopiskelijan (TC) toimesta, jota ohjaa vastaava fysioterapeutti.  
Tiedon säilytys, arkistointi ja luottamuksellisuus 
Suostumuslomakkeiden allekirjoittamisen jälkeen saatte yksilöllisen tunnistenumeron (ID), jota tullaan 
käyttämään kaikissa teistä kerätyissä tiedoissa (kyselyt, videot yms.). Tunnistenumerolla varustetut 
lomakkeet säilytetään SAMK:in toimistossa lukitussa kaapissa ohjaavan fysioterapeutin toimesta. 
Avaintiedosto, joka yhdistää teidän tietonne (nimen ja puhelinnumeron) ID-numeroon sekä 
suostumuskaavake varastoidaan erillään kerätystä materiaalista tietoturvan varmistamiseksi. Videot teidän 
kävelystänne säilytetään Tomas Cervinkan henkilökohtaisessa pilvipalvelussa salasanalla suojattuna. Kerätty 
tieto säilytetään tutkimustarkoituksessa 10 vuoden ajan.  
 
Mitään teitä koskevaa tietoa ei tulla jakamaan kenellekään ilman teidän lupaanne tai lain velvoitusta. Jos 
tutkimustuloksia julkaistaan, teidän nimeänne ei tulla käyttämään, eikä tietoja, joista teidän 
henkilöllisyytenne voitaisiin todeta, tulla julkaisemaan ilman teidän suostumustanne.  
 
Oikeutenne osallistujana 
Jos päätätte osallistua tähän tutkimukseen, voitte koska tahansa vetäytyä siitä joutumatta selittämään 
päätöstänne. Jos vetäydytte tutkimuksesta, teillä on mahdollisuus poistaa kaikki tutkimuksessa kerätty teitä 
koskeva tieto, lukuun ottamatta tietoa joka on jo ehditty julkaisemaan.  
 
Jos tutkimuksen aikana huomataan jotakin odottamatonta tai normaalista poikkeavaa reaktiota, ilmoitamme 
tästä teitä hoitavalle taholle (lääkärillenne tai fysiatrillenne), jotta saatte asianmukaista jälkihoitoa.  
 
Jos teille aiheutuu vahinkoa tähän tutkimukseen osallistumisesta kaikki tarvittavat hoidot tehdään teille 
mahdollisiksi koulun vakuutuksen kautta.  
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Kysymykset tutkimuksesta
Jos teillä on kysymyksiä tai huolenaiheita liittyen tutkimukseen tai haluaisitte muuten puhua tutkijoiden
kanssa mistä syystä tahansa, olkaa hyvä ja soittakaa: fysioterapiaopiskelija Tomas Cervinkalle: +358 xx xxx
xxxx tai tutkimusta ohjaavalle fysioterapeutille, Maija Kangasperkolle: +358 xx xxx xxx.
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Suostumus 
 
 
Tutkimuksen otsikko Keep Improving Kinematics in Walking (KIK-Walk): Functional Electric Stimulation 
Based Locomotor Training 
Tutkija   Tomas Cervinka, TkT, Ft opiskelija (Am) 
Vastaava ohjaaja  Maija Kankasperko, Ft (Am) MSc. 
 
 
Olen saanut yllä mainittua tutkimusta koskevaa tietoa ja lukenut saamani kirjallisen tiedotteen, jossa on 
selvitetty tutkimuksen tarkoitus, luonne sekä käytettävät tutkimusmenetelmät. Tiedotteessa on selvitetty 
tutkimuksesta tutkimushenkilölle koituva hyöty sekä mahdolliset riskit ja haitat. Minulla on ollut 
mahdollisuus esittää tutkijoille kysymyksiä tutkimuksesta ja siihen osallistumisesta sekä saada vastaukset 
kysymyksiini. 
Minulle on selvitetty, että tutkimuksessa kerätty aineisto tullaan säilyttämään Satakunnan 
Ammattikorkeakoulussa (SAMK), joka on turvallisesti säilytetty lukollisessa kaapissa vastaavan 
fysioterapeutin toimistossa. Vain tiedot, jotka liittyvät ikääsi, sukupuoleesi, kuluneeseen aikaan 
aivohalvauksesta tai muusta vauriosta, vaurion kestoon, haitallisten vammojen lukumäärään, hoitoon 
sitoutumiseen ja osallistumiseen, ja kyselyistä saatuihin tietoihin (fyysisen toimintakyvyn-, elämänlaatu- 
sekä potilaspalvelun laatua koskevat kyselyt) tallennetaan sähköisesti OneDrive -pilvipalveluun joka on 
suojattu henkilökohtaisin käyttäjätunnuksin ja salasanoin. Käyttöoikeus anonymisoituun aineistoon 
voidaan hakemuksesta antaa muille tutkijoille vain tutkimustarkoituksessa. Kerättyä aineistoa saa käyttää 
vain tiedotteessa mainittuun tarkoitukseen. Tutkimustuloksia julkaistaessa henkilöllisyyttäni ei missään 
vaiheessa paljasteta. 
Minulla on ollut riittävästi aikaa harkita tutkimukseen osallistumista. Suostun vapaaehtoisesti tähän 
tutkimukseen ja annan tutkijoille edellä esitetyn mukaisesti luvan kerätä, rekisteröidä ja käyttää minua 
koskevia tutkimukseen liittyviä tietoja. Tiedän, että voin halutessani milloin tahansa syytä ilmoittamatta 
perua tämän suostumukseni. 
 
Lisäys 
Annan tutkijoille luvan alaraajan kuvaamiseen. Allekirjoittamalla tämän suostumuksen ymmärrän, että 
minua koskevia valokuva- tai videotallenteita voidaan hyödyntää opinnäytetyössä; koulutustarkoituksiin, 
sekä materiaali on esillä julkisessa Linked-In:ssa ja YouTube-videontoistopalvelussa. 
Tämä suostumuslomake on allekirjoitettu kahtena kappaleena, joista toinen jää minulle ja toinen tutkijoille 
arkistoitavaksi. 
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Suostumuksen antaja päiväys Allekirjoitus 
 
 etunimet 
 
sukunimi 
 
 puhelin 
 
 
Suostumuksen 
vastaanottaja 
päiväys allekirjoitus 
 arvo/ammatti 
FT opiskelija 
nimenselvennys 
Tomas Cervinka 
 puhelin
+358 xx xxx xxxx
muut yhteystiedot
xxxxx.xxxxxxx@student.samk.fi
 
OTHER MATERIAL USED IN THE STUDY 
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Appendix 1: Modified Outpatient Quality of Service Survey (QuestionPro) 
Participant ID: _______________     Date: _________________ 
 
Q1. On a scale of 0-10, considering your complete experience with our physiotherapy clinic, how likely 
would you be to recommend us to a friend or colleague? (0 being Very Unlikely and 10 being Very Likely) 
 
 
Q2. Please state your level of satisfaction with the process of booking an appointment with your 
physiotherapist.  
 Very 
Satisfied 
 Satisfied  Neutral  Unsatisfied  
Very 
Unsatisfied 
 
Q3. Are you currently covered under a private health insurance plan?  
 
Yes  No 
 
Q4. When requesting an appointment, were you given a chance to see your primary physiotherapist? 
 
Always  Sometimes  Never 
 
Q5. How long did you have to wait (past the appointment time) to meet the physiotherapist?  
 0-30 
minutes 
 
30-60 
minutes 
 
More than 
an hour 
 
More than 
two hours 
 
Q6. Is this physiotherapy clinic the one you usually visit in case of a need for rehabilitation? 
 
Yes  No 
 
Q7. Since how many months/years have you been visiting this physiotherapy clinic?  
 < 6 
months 
 
> 6 months 
to a year 
 
≥ 1 but < 3 
years 
 
≥ 3 but < 5 
years 
 ≥ 5 years 
 
Q8. In the past year, how frequently did you visit this physiotherapy clinic?  
 Not 
at all 
 1x  2x  3x  4x  5x  ≥ 5x 
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Q9. On average, how often do you visit a physiotherapy clinic in a given year?  
 Less than 
1 visit 
 1-2 visits  3-5 visits  
More than 
5 visits 
 
Q10. How often did you receive conflicting information from different medical care professionals at this 
clinic?  
 
Always  Sometimes  Never 
 
Q11. Were you informed about possible side effects and/or adverse symptoms of the therapy prescribed 
to you? 
 
Yes  No 
 
Q12. How satisfied were you with the following during your treatment at our physiotherapy clinic? 
 Very 
Satisfied 
 Satisfied  Neutral  Unsatisfied  
Very 
Unsatisfied 
          
Professionalism of our 
staff 
         
          
Hygiene at the clinic          
          
Care provided by 
personnel 
         
          
Time that a PT spent 
with you 
         
          
Attentiveness towards 
concerns 
         
 
Q13. Were you asked today, if you had seen any health care providers besides us since your last visit?  
 
Yes  No 
 
Q14. Do you feel that our work hours are well suited to treat you? 
 Strongly 
Agree 
 Agree  Neutral  Disagree  
Strongly 
Disagree 
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Q15. How convenient is our facility’s location for you?  
 Somewhat 
Convenient 
 Convenient  Neutral  Inconvenient  
Somewhat 
Inconvenient 
 
Q16. How easy was it to find your way to the clinic across the shopping center?  
 
Very Easy  
Easy 
 
 Neutral  Difficult  
Very 
Difficult 
 
Q17. How would you rate us on the following parameters? 
 Very 
Good 
 Good  Average  Poor  Very Poor 
          
Our concern for your 
privacy and transparency 
         
          
Quality of service received          
          
Information provided           
 
Q18. Do you know about all the healthcare services we offer?  
 I was told about all of them without asking 
  
 I was told after I asked for them 
  
 I was not told about them 
 
Q19. How easy was it to get a follow-up appointment? 
 
Very Easy  Easy  Neutral  Difficult  
Very 
Difficult 
 
Q20. Have we helped you find other services you need that we do not provide?  
 
Yes  No 
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Q21. Do you have any other feedback for us? 
 
 
Modified from a free template available at https://www.questionpro.com/survey-templates/hospital-
patient-satisfaction/ 
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Liite 1: Muokattu avohoitopotilaan palvelun laatua koskeva mielipidekysely 
(QuestionPro)) 
Osallistujan nro: _______________     Päivä: _________________ 
 
K1. Vastatkaa asteikolla 0 -  10, kun ajattelette kokemustanne fysioterapiaklinikallamme kokonaisuutena, 
kuinka todennäköisesti suosittelisitte meitä ystävällenne tai työtoverillenne? (0 merkitsee Hyvin 
epätodennäköisesti ja 10 merkitsee Hyvin todennäköisesti) 
 
 
K2. Esittäkää mielipiteenne, kuinka tyytyväinen olette fysioterapeuttiajan varaamiseen.  
 Hyvin 
tyytyväinen 
 Tyytyväinen  
En osaa 
sanoa 
 Tyytymätön  
Hyvin 
tyytymätön 
 
K3. Onko Teillä tällä hetkellä voimassa olevaa yksityistä terveysvakuutusta?  
 
Kyllä  Ei 
 
K4. Kun varasitte tapaamisaikaa, oliko teillä mahdollisuus varata aika omalle fysioterapeutillenne?? 
 
Aina  Joskus  Ei koskaan 
 
K5. Kuinka kauan Teidän täytyi odottaa yli varatun tapaamisajan fysioterapeutille pääsyä?  
 0-30 
minuuttia 
 
30-60 
minuuttia 
 
Enemmän 
kuin yksi tunti 
 
Enemmän kuin 
kaksi tuntia 
 
K6. Onko tämä fysioterapiaklinikka se paikka, jossa yleensä käytte tarvitessanne kuntoutusta? 
 
Kyllä  Ei 
 
K7. Kuinka kauan (kuukautta/vuotta) Olette käyneet tällä fysioterapiaklinikalla? 
 
vähemmän 
kuin 6 
kuukautta 
 
enemmän kuin 
6 kuukautta - 
vuoden 
 
enemmän kuin 
vuoden mutta 
alle 3 vuotta 
 
 3 – 5 
vuotta  
 
enemmän 
kuin 5 
vuotta 
 
    
     
 
K8.  Viimeksi kuluneen vuoden aikana, kuinka usein kävitte tällä fysioterapiaklinikalla?  
 En yhtään 
kertaa 
 1x  2x  3x  4x  5x  ≥ 5x 
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K9. Kuinka usein keskimäärin käytte fysioterapiaklinikalla vuoden aikana/vuosittain?  
 Vähemmän 
kuin kerran 
 1-2 kertaa  3-5 kertaa  
Enemmän 
kuin 5 kertaa 
 
K10. Kuinka usein saitte klinikallamme ristiriitaista tietoa eri lääketieteen edustajien taholta? 
 
Aina  Joskus  En koskaan 
 
K11. Kerrottiinko Teille mahdollisista sivuvaikutuksista ja/tai vastakkaisista oireista, joita Teille määrätty 
hoito voi aiheuttaa? 
 
Kyllä  Ei 
 
K12. Kuinka tyytyväinen olitte seuraavissa fysioterapiaklinikkaamme koskevissa seikoissa hoitonne 
aikana? 
 Hyvin 
tyytyväinen 
 Tyytyväinen  
En osaa 
sanoa 
 Tyytymätön  
Hyvin 
tyytymätön 
          
Henkilökuntamme 
ammattitaito 
         
          
Klinikkamme hygienia          
          
Henkilöstön tarjoama 
hoiva 
         
          
Aikaan, jonka 
fysioterapeutti vietti 
kanssanne 
 
 
 
 
 
 
 
 
 
     
     
          
Huomiot huolianne 
kohtaan 
         
 
K13. Kysyttiinkö Teiltä tänään, että oletteko käyneet hoitomme ohella viime kerran jälkeen jonkin muun 
terveysammattilaisen luona?  
 
Kyllä  Ei 
 
K14. Tuntuuko Teistä siltä, että työaikamme on sopiva hoitamiseenne? 
 Täysin samaa 
mieltä 
 
Samaa 
mieltä 
 
En osaa 
sanoia 
 Eri mieltä  
Täysin eri 
mieltä 
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K15. Kuinka sopiva palvelujemme sijainti on Teille?   
 Melko 
sopiva 
 Sopiva  Neutraali  Hankalaa  
Hieman 
hankalaa 
 
K16. Kuinka helppoa Teidän oli löytää klinikalle ostoskeskuksen läpi?  
 Hyvin 
helppoa 
 Helppoa  
En osaa 
sanoa 
 Vaikeaa  
Hyvin 
vaikeaa 
 
K17. Kuinka arvioisitte meitä seuraavissa tekijöissä? 
 Oikein 
hyvä 
 Hyvä  
Keskinker-
tainen 
 Heikko  
Hyvin 
heikko 
          
Huolemme yksityi-
syydestäsi ja 
avoimuutemme 
 
 
 
 
 
 
 
 
 
     
     
          
Annetun palvelun laatu          
          
Tarjottu tieto          
 
K18. Tiedättekö kaikista tarjoamistamme terveyspalveluista?  
 Minulle kerrottiin niistä kysymättä. 
  
 Minulle kerrottiin niistä kysyttyäni. 
  
 Minulle ei kerrottu niistä. 
 
K19. Kuinka helppoa oli saada seuraava käyntiaika? 
 Erittäin 
helppoa 
 Helppoa  
En osaa 
sanoa 
 Vaikeaa  
Hyvin 
vaikeaa 
 
K20. Olemmeko auttaneet Teitä löytämään muita tarvitsemianne palveluita, joita emme itse tarjoa?  
 
Kyllä  Ei 
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K21. Onko Teillä jotain muuta meille annettavaa palautetta? 
 
 
Modified from a free template available at https://www.questionpro.com/survey-templates/hospital-
patient-satisfaction/ 
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Appendix 2:  Discharge Criteria 
Participants may be withdrawn from the study if they exhibit the following: 
i. Participant has met all the requirements of the KIK-Walk Protocol 
ii. In the best professional judgment of the participant fails to demonstrate consistent compliance 
with on-site therapy. 
ii. Physician discharges participant from the study. 
iv. Participant/family elects to discontinue services. 
v. Participant for any reason is not able to meet 80% of their scheduled appointments.  If patient 
will miss 5 or more consecutive treatment sessions. 
  
 KIK-WALK Study – Other material, Tomas Cervinka  Page 10 of 17 
 
Appendix 3: Inclusion criteria check list 
 
Participant ID: _______________     Date: _________________ 
Assessed by: ________________ 
 
Age ≥ 18 years 
Medically stable condition 
Walking independently either with use of assistive devices or with speed < 0.5 m/s (preclusion of 
being community walker) during a 2 minute walking test.  
Willingness and possibility to participate in FES-walking therapy 
Responsiveness to electrical stimulation 
Proximity to Tutoris Oy for realistic access 
Access to reliable transportation 
 
SCI specific 
Traumatic or incident caused motor incomplete SCI with non-progressive spinal cord lesion at level 
T10 or above; (T11 and T12 may be considered in absence of lower motor neuron signs)  
Duration of injury at least 18 months with stable with no deteriorating medical condition 
 
Stroke specific 
First episode of hemiplegia at least 3 months in duration as a result of a stroke with a stable 
neurology 
PNS without evidence of uncontrollable knee hyperextension 
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Appendix 4: Exclusion criteria check list 
Participant ID: _______________     Date: _________________ 
Assessed by: ________________ 
 
Motor Complete SCI or bilateral stroke 
Tendon lengthening surgery in the last 6 months. If greater than 6 months, require surgeon's 
approval 
Contraindications to FES (cardiac pacemakers, skin scratches or grade 2 or 3 pressure ulcers at 
potential electrode sites, denervation of targeted muscles)  
Grade 4 Pressure ulcers anywhere on the lower extremities 
Uncontrolled Hypertension or symptoms of orthostatic hypotension when standing for 15 minutes 
Untreated autonomic dysreflexia 
Subjects with a history of cardiovascular disease, must obtain medical clearance from their primary 
care physician before inclusion 
Amyotrophic Lateral Sclerosis or lower motor neuron disorders 
Dependent on ventilator or unable to voluntarily extend head 
Painful musculoskeletal dysfunction (e.g., knee deformity) or unhealed fractures 
Fixed muscle contracture 
Sensory or motor peripheral neuropathy 
Unable to follow/understand verbal commands 
Pregnancy 
Psychological disorders 
Uncontrolled seizure disorder 
Illegal drug use  
MRSA or other Infectious Diseases requiring contact droplet precautions 
Active oncology diagnosis 
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Appendix 5: Passive range of motion and manual muscle testing assessment form 
 
Participant ID: _______________     Date: _________________ 
Assessed by: ________________ 
 
Passive range of motion 
            Right limb             Left limb 
  Flexion   Extension  Flexion   Extension 
Hip  
 
  Flexion   Extension  Flexion   Extension 
Knee 
 
  Dorsi Flexion  Plantar Flexion  Dorsi Flexion  Plantar Flexion 
Ankle 
 
 
Manual muscle testing 
Muscle    Score right limb   Score left limb 
Gluteus maximus 
Quadriceps 
Hamstring 
Tibialis anterior 
Calf 
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Appendix 6:  self-reported quality of life (EQ-5D)  
  
 Finland (Finnish) © 1993 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Terveyskysely 
 
 
Suomenkielinen versio Suomea varten 
 
(Finnish version for Finland) 
 
  
2 
 
Finland (Finnish) © 1993 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group 
Olkaa hyvä ja merkitkää rastilla (x), yksi rasti kunkin alla olevan ryhmän kohdalle, mikä 
väitteistä kuvaa parhaiten terveydentilaanne tänään: 
  
Liikkuminen  
Minulla ei ole vaikeuksia kävelemisessä ❑ 
Minulla on jonkin verran vaikeuksia kävelemisessä ❑ 
Olen vuoteenomana ❑ 
  
Itsestään huolehtiminen 
 
Minulla ei ole vaikeuksia huolehtia itsestäni ❑ 
Minulla on jonkin verran vaikeuksia peseytyä tai pukeutua itse ❑ 
En kykene peseytymään tai pukeutumaan itse ❑ 
  
Tavanomaiset toiminnot (esim. ansiotyö, opiskelu, kotityö, vapaa-ajan 
toiminnot) 
 
Minulla ei ole vaikeuksia suorittaa tavanomaisia toimintojani ❑ 
Minulla on jonkin verran vaikeuksia suorittaa tavanomaisia toimintojani ❑ 
En kykene suorittamaan tavanomaisia toimintojani ❑ 
  
Kivut / vaivat 
 
Minulla ei ole kipuja tai vaivoja ❑ 
Minulla on kohtalaisia kipuja tai vaivoja ❑ 
Minulla on ankaria kipuja tai vaivoja ❑ 
  
Ahdistuneisuus / Masennus 
 
En ole ahdistunut tai masentunut ❑ 
Olen melko ahdistunut tai masentunut ❑ 
Olen erittäin ahdistunut tai masentunut ❑ 
  
3 
 
Finland (Finnish) © 1993 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
0 
 
 
 
 
Auttaaksemme ihmisiä sanomaan, kuinka hyvä tai huono 
jokin terveydentila on, olemme piirtäneet lämpömittaria 
muistuttavan asteikon. Parasta terveydentilaa, jonka 
voitte kuvitella, merkitään siinä 100:lla ja huonointa 0:lla. 
 
Haluaisimme Teidän osoittavan tällä asteikolla, miten 
hyvä tai huono Teidän terveytenne on mielestänne 
tänään. Olkaa hyvä ja tehkää tämä vetämällä alla 
olevasta laatikosta viiva siihen kohtaan asteikolle, joka 
osoittaa, miten hyvä tai huono terveydentilanne on 
tänään. 
 
 
 
 
Paras 
kuviteltavissa 
oleva 
terveydentila 
Huonoin 
kuviteltavissa 
oleva 
terveydentila 
Terveydentilani 
tänään 
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Appendix 7: Rivermead Mobility Index 
  
   
  
      
   
RIVERMEAD MOBILITY INDEX
Kuntoutujan nimi   _______________________                  Testaaja_____________
Pvm ___.___.____
Pisteytysohje: Jokaisesta kyllä-vastauksesta saa yhden pisteen. Mikäli henkilö arvioi, 
ettei pysty suoriutumaan tehtävästä, pistemäärä on 0. Maksimi on 15 pistettä. 
Tehtävä numero 5 havainnoidaan.
Pisteet
1. Kääntyminen sängyssä
 Pystytkö kääntymään selinmakuulta kylkimakuulle ilman apua?
2. Makuulta istumaan
 Pystytkö nousemaan makuuasennosta sängyn reunalle istumaan itsenäisesti?
3. Istumatasapaino
 Pystytkö istumaan sängyn reunalla ilman tukea vähintään 10 sekuntia?
4. Istumasta seisomaan nousu
Pystytkö nousemaan tuolilta seisomaan enintään 15 sekunnissa ja
 seisomaan 15 sekuntia? Voit käyttää apuna käsiä ja tarvittaessa apuvälinettä.
5. Seisominen tuetta
 Pystytkö seisomaan tuetta 10 sekuntia (havainnoidaan)
6. Siirtyminen
 Pystytkö siirtymään sängystä tuoliin ja takaisin ilman apua?
7. Käveleminen sisällä
 Pystytkö kävelemään 10 metriä sisällä, tarvittaessa apuvälinein?
8. Portaat
 Pystytkö nousemaan portaita yhden kerrosvälin ilman apua?
9. Käveleminen ulkona
 Pystytkö kävelemään ulkona asfaltilla ilman apua?
10. Käveleminen sisällä ilman apuvälineitä
 Pystytkö kävelemään sisällä 10 m ilman apuvälineitä tai toisen henkilön tukea?
11. Esineen poimiminen
 Pystytkö nostamaan esineen 5 metrin kävelymatkan päästä ja palamaan takaisin?
12. Käveleminen ulkona maastossa
Pystytkö kävelemään epätasaisessa maastossa, esim. ruohikolla, soralla tai jäällä?
13. Kylpeminen
 Selviydytkö suihkuun/kylpyyn menosta ja tulosta sekä peseytymisestä itsenäisesti?
14. Neljä porrasta
 Pystytkö kulkemaan neljä porrasta ylös ja alas ilman kaidetta, tarvittaessa apuvälinein?
15. Juokseminen
 Pystytkö juoksemaan tai kävelemään ontumatta neljässä sekunnissa 10 metriä?
 YHTEENSÄ
 
 
Lähde: Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the 
Rivermead Motor Assessment. Int Disabil Stud 1991; 13:50–4. 
 
Suomennos on laadittu vuonna 2002 Suomen aivotutkimus- ja kuntoutuskeskus Neuronissa englanninkielisestä 
lomakkeesta. Käännöstyöryhmään kuuluivat Sinikka Peurala, Ina Tarkka, Kauko Pitkänen ja Juhani Sivenius 
ID 027 / 14.6.2011 
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Appendix 8: Event reporting 
Participant ID: _______________       
Date 
DD/MM/YY 
Event Action Initials 
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Appendix 9: Therapy adherence form 
 
Participant ID: _______________       
Session 
no. 
Date 
DD/MM/YY Attended Therapy description 
Duration 
min 
Initials 
1 
     
2 
     
3 
     
4 
     
5 
     
6 
     
7 
     
8 
     
9 
     
10 
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11 
     
12 
     
13 
     
14 
     
15 
     
 
KIK-Walk Study 
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Data Management Plan 
 
Title of Study Keep Improving Kinematics in Walking (KIK-Walk): Functional Electric Stimulation 
Based Locomotor Training 
Primary Investigator  Dr. Tomas Cervinka, PT student (Am) 
Supervisors  Maija Kankasperko, PT (Am) MSc. 
 
Timeline, Data Collection and Analysis 
The study will start in November 2019 and last until August 2020. The study will be divided into three 
phases, preparation, intervention and data analysis. The preparation part will begin in November 2019 
and last until January 2020. The intervention part will start on January 20th, 2020 and last until February 
21st, 2020, and outcome assessment part will begin in June 2020 and last until August 2020. Recruitment 
will start on December 1st and last until 1 individual will agree to participate in the study.  
The baseline visit (the first day of intervention) will take place at the Satakunta University o Applied Science 
(SAMK) on January 20th, 2020. However, the starting date may be slightly advanced or postponed based 
on participants needs. The intervention will last 5 weeks, and all sessions will be held at SAMK. The 
longitudinal follow-up testing will take place after the last intervention on February 21st, 2020.  
The processing and transfer of collected data to an electronic format will take place at SAMK at the end of 
February 2020. The electronic files will be stored on a private OneDrive school account of Tomas Cervinka. 
The data analysis, evaluation and interpretation will start on June 1st, 2020 and last until August 31st, 2020.  
A table outlining the study plan, and detailed information concerning questionnaires and data collection 
is presented below (Table 1 and 2). 
Table 2: Timeline of the study 
Period 
P
H
A
SE
 I
 
Preparation Recruitment 
P
H
A
SE
 I
I 
Intervention 
P
H
A
SE
 I
II
 
Processing Analysis 
 
Location 
Nov 
2019 
X     SAMK 
Dec 
2019 
X X    SAMK 
Jan 
2020 
 X X   SAMK 
Feb 
2020 
  X X  SAMK 
Mar 
2020 
     
 
Apr 
2020 
     
 
May 
2020 
     
 
Jun 
2020 
    X TC home 
Jul 
2020 
    X TC home 
Aug 
2020 
    X TC home 
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1) First stage 
a. Recruitment 
During this process, the physiotherapy student (Tomas Cervinka) with supervising leading 
physiotherapist (Maija Kangasperko) will assess potential participants in face-to-face interview 
and 2-minute walking test according to inclusion and exclusion criteria. The interview will take 
place at SAMK facilities. The interview and test results will be recorded on a paper checklist forms 
(Appendix 3 and 4). If an individual meets all the inclusion criteria, potential participant will be 
provided additional information concerning the study and offered to sign a consent form to 
continue the progress. The potential participant will be also informed that he/she can withdraw 
from the study at any point without giving any reason. 
If the potential participant agrees to participate in the study, the he/she will receive an 
identification numerical code (starting by 001) that will be used on all following testing 
documents, questionnaires and study results. As the documents (inclusion/exclusion criteria check 
list and consent form) contain participant’s name, given identification numerical code and 
telephone number, they will be stored in a separate envelope in a locked cabinet at the SAMK’s 
office of the leading physiotherapist to prevent any possible identification of study participating 
person by any unauthorized person. If an individual doesn’t meet all the inclusion criteria or will 
not present his/her interest in undergoing the study, the checklist documents will be shredded 
and disposed.  
b. PT assessment 
The consenting participant will then undergo a face-to-face physiotherapy assessment to evaluate 
his/her skin integrity, passive range of motion in hips, knees and ankles, and muscle strength of 
gluteus maximus, quadriceps, hamstring, tibialis anterior and calf muscles by manual muscle 
testing. These tests will be performed by the leading physiotherapist or the physiotherapy student 
under direct supervision of the leading physiotherapist to guarantee individual’s safety during the 
locomotion triggered by FES. The tests will be performed at SAMK facilities and the results will be 
recorded on a paper form (Appendix 5). 
If the consenting participant will pass the safety testing and will be still willing to continue the 
study, he/she will be offered a start day of the study, the form containing results of the physical 
assessment will be stored in an envelope in a locked cabinet at the SAMK’s office of the leading 
physiotherapist, and recruitment process will be terminated. If an individual doesn’t pass the 
safety criteria or will not present his/her interest in undergoing the study, the checklist document 
will be shredded and disposed, and recruitment process will continue. 
 
2) Second stage 
During the baseline visit (January 20th, 2020), the physiotherapy student (under supervision of the 
leading physiotherapist) will administer and collect following self-reported questionnaires to the 
study participant prior onset the actual intervention: 
a. Self-reported quality of life (EQ-5D, Appendix 6) 
b. Rivermead Mobility Index (RIM, Appendix 7) 
The test results will be recorded on paper forms as provided in appendixes. Further, the physiotherapy 
student will record participant’s age, sex and duration of the disease. No other personal details will 
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be recorded. In addition, the physiotherapy student will record a short video of participant’s gait on a 
treadmill prior the use of FES-stimulation during week 1, and with the use of FES during week 1 and 
week 5 to observe the intervention progress. The video will be recorded only in view from knees down, 
therefore, the participant can’t be identified. 
During the intervention participant will be asked to keep a self-administered diary and record any 
minor/major adverse event that occurred. Investigators (Tomas Cervinka and Maija Kangasperko) will 
follow-up with these recording at the beginning of every therapy session and record the events on a 
paper form (Appendix 8). Further, investigators will use the same form to record injuries during 
therapy and all issues that appeared during the therapy and how they were addressed. In addition, 
investigators will record on a paper form (Appendix 9) the number of sessions (frequency) and 
duration of training sessions attended, and ask the participant to fill the RMI on weekly basis. 
After the therapy cessation (February 21st, 2020), the same questionnaires (EQ-5D and RMI) as during 
the baseline visit will be administered and collected by the physiotherapy student under supervision 
on the leading physiotherapist. In addition, a written form for self-reported survey of service quality 
will be administered (Quality of Services Survey - Appendix 1) and collected by investigators. 
Table 2: Summary of timeline of administered questionnaires and data collection during intervention 
Week Session EQ-5D RMI 
Adverse event 
reporting 
Therapy 
adherence 
Quality of 
Service Survey 
Video 
Collected 
by 
1 
Baseline X X  X  X TC or MK 
2   X X   TC or MK 
3   X X   TC or MK 
2 
4  X X X   TC or MK 
5   X X   TC or MK 
6   X X   TC or MK 
3 
7  X X X   TC or MK 
8   X X   TC or MK 
9   X X   TC or MK 
4 
10  X X X   TC or MK 
11   X X   TC or MK 
12   X X   TC or MK 
5 
13  X X X   TC or MK 
14   X X   TC or MK 
Follow up X X X X X X TC or MK 
All the questionnaires and data recording will be done by the leading physiotherapist (MK) or by the physiotherapy student (TC) under direct 
supervision of the leading physiotherapist.  
3) Third stage 
All collected (de-identified) data will be processed by physiotherapy student (Tomas Cervinka) at the 
Satakunta University of Applied science and transferred to an electronic form that will be stored on a 
private OneDrive school account of Tomas Cervinka. The identifiable forms (inclusion/exclusion 
criteria) and consent form will remain safely stored in a locked cabinet at the SAMK’s office of the 
leading physiotherapist. After that, Tomas Cervinka will analyze and evaluate/interpret the data at his 
private computer at his home. As this is a case study, the statistical testing is not applicable and 
analysis will only include basic data comparison (differences pre-post intervention), and evaluation of 
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adherence and self-perceived satisfaction with the intervention. In addition, a bachelor thesis will be 
written with description of study results and all the adverse events or difficulties that investigators or 
participant had to face during the intervention. 
Data storage, confidentiality and archiving plan 
After signing the consent form, the participant will receive a unique identification (ID) number and only 
this ID will be used on all paper forms and questionnaires that will be later collected by Tomas Cervinka or 
Maija Kangasperko during the intervention. Concerning personal information, only age, sex and time post 
stroke will be recorded in addition to the name and telephone number. The ID will be given to the 
participant so that the identifying information (name and telephone number) can be removed from the 
collected data. Further, a video recording of participants gait (view from knees down) will be stored in 
personal storage cloud of Tomas Cervinka without any personal details and protected by a password. 
All collected data, except the video recordings, will be stored in envelopes in a locked cabinet at the 
SAMK’s office of the leading physiotherapist. However, a key file linking participant information (name and 
telephone number) to the ID together with consent form and inclusion/exclusion criteria forms will be 
stored separately from the other collected data in a closed envelope to prevent any possible identification 
of study participating person by any unauthorized person. The video recording (without personal details) 
will be used for introduction of this intervention approach at social media as YouTube or LinkedIn of Tomas 
Cervinka. In addition, the video will be used for educational purposes and in bachelor thesis of Tomas 
Cervinka. 
During the analysis part of the study, Tomas Cervinka will transfer the collected data to an electronic form. 
However, the only patient related information that will appear in the electronic databases and bachelor 
thesis of Tomas Cervinka, will be age, sex, and time post stroke. The identifiable forms (inclusion/exclusion 
criteria) and consent form will remain safely stored in a locked cabinet at the SAMK’s office of the leading 
physiotherapist. 
All stored documents of consenting participant will be retained for research purposes for 10 years upon 
the study competition. If potential participant declines to participate or doesn’t get through the selection 
assessment chain, his/her collected documents/data will be shredded and disposed immediately. 
Data ownership and usage rights 
By signing the consent form and agreeing to participate in the study, the study participants will give their 
permission to use all collected data for future analyses and other research purposes. It also means that 
the data collected during this study (age and sex, time post stroke, count of adverse events, study 
adherence and engagement and results of self-reported questionnaires may be shared outside of the 
Satakunta University of Applied Science with permission from investigators. 
KIK-Walk Study 
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Research Ethics 
 
Title of Study Keep Improving Kinematics in Walking (KIK-Walk): Functional Electric Stimulation 
Based Locomotor Training 
Primary Investigator  Dr. Tomas Cervinka, PT student (Am) 
Supervisors  Maija Kankasperko, PT (Am) MSc. 
 
 
Potential Risks to Participants 
The functional electrical stimulation (FES) is generally well tolerated and serious medical complications are 
rare. The most common problems with FES are discomfort or pain (“pins and needles” like sensation on 
skin), skin redness or irritation, nausea, light-headedness. The discomfort can range from a mild tingling 
to almost a burning sensation depending on stimulation parameters. Nevertheless, these parameters can 
be easily adjusted to decrease the discomfort in most of the cases. The skin redness may be left in places 
where electrodes were placed on the skin because of glue used on self-adhesive electrodes, but this 
redness usually disappears within an hour. In rare cases, the non-latex hypoallergenic electrodes have to 
be used to solve the problem. 
Less common risk or rare side effects are skin breakdown, fainting, worsening of muscle spasms, muscle 
and joint injuries (strains or swelling), bone fractures in case of severe osteoporosis, and mild electrical 
burns near electrodes in case of improper use or faulty equipment. In this cases, the intervention will be 
immediately terminated. 
Ethical Considerations 
The research will be conducted according to the Finnish Advisory Board on Research Integrity (TENK 2012), 
the Administrative Procedure Act (434/2004) Section 28, and the Finnish Personal Data (Data Protection 
Regulation). Research Ethics Board approval will be sought at the Ethics Board of Satakunta District (school 
site). The patient information will not be stored apart from the name and telephone number on a consent 
form, name on check list forms related to inclusion/exclusion criteria, and age, sex and duration of disease 
for reporting purposes. The afore mentioned forms will be stored in a separate envelope in a locked 
cabinet at the SAMK’s office of the leading physiotherapist to prevent any possible identification of study 
participating person by any unauthorized person.  
The participant will receive a unique identification (ID) number to be used on all other forms and in 
electronic databases. A key file linking participant information to the ID will be stored in the afore 
mentioned separate envelope so that identifying information can be removed from the collected data. All 
other forms and study data files will be stored in separate envelope from the afore mentioned in a locked 
cabinet of the leading physiotherapist. During the recruiting process, all Individuals who indicate that they 
are not interested in participating will not be contacted further. Written informed consent will be obtained 
from participant prior to testing of physical suitability for the FES intervention. Participant will be informed 
that due to visits in physiotherapy school setting, and despite collecting only minimum identifiable data, 
he/she can be recognized at school premises and asked questions related to his/her numerous school visits 
during the intervention. In addition, the participant will be informed that he/she can withdraw from the 
study at any time without giving reasons.  
 KIK- WALK Study - Research Ethics, Tomas Cervinka  Page 2 of 2 
 
In case, there is a need to modify the study protocol during the ongoing study in a way that it would deviate 
from the approved version, researchers will suspend the study and apply for new ethical permit by a 
research plan addendum. Upon successful application, the participant will be given addendum of the 
previous conflict of interest and patient information form. If the participant indicates that he/she is not 
interested in participating the updated protocol, he/she will not be contacted further. 
Potential Benefits of the Proposed Research  
The benefits of the FES therapies among Stroke are well known from various research studies and 
described in the best practice accreditation guidelines in Stroke rehabilitation of some countries. These 
benefits include muscle hypertrophy and associated increased vascularization, faster extremity motor 
recovery resulting in improved recovery of independent walking (a major goal of an individual 
rehabilitation plan), and improvements in overall health and well-being. Health improvements can include 
better cardiovascular and pulmonary function, increased bone density and decreased spasticity. 
Nevertheless, the use of neuromuscular stimulation among physiotherapists and especially in task-specific 
practices, one of the key components of activity-based therapies, is still low.  
Therefore, this case study is proposed to introduce and eradicate barriers of the FES and specifically the 
FES-walking therapeutic approach in clinical setting in Finland. The study, developed protocol, may be used 
to improve current rehabilitation strategies, used by health care professionals in rehabilitation clinic 
nationwide, targeting “out-patient” individuals with Stroke. It is anticipated that implementing this new 
protocol will provide opportunities for enhanced clinical care, education and professional development as 
well as new research opportunities for the Satakunta University of Applied Science Research Program. 
Further, the study will provide a sound foundation for future prospective longitudinal studies of FES-based 
therapies in acute patient care. The incorporation of FES-based therapies may improve and speed up 
individuals’ recover. This will result in shorter hospitalization times and improved self-ambulatory and -
caring in individual’s own home environment. Consequently, incorporation of FES-based therapy will result 
in enormous savings in health and social care costs. Given the low of risk associated with participation and 
the benefit to the community the risk: benefit ratio is favourable.  
Knowledge Translation 
KIK-Walk project thesis presentation session will be held at Satakunta University of Applied Science to 
increase awareness of FES-based therapies in neurological population among staff, students and visitors. 
A summary of the results and information on KIK-Walk project will be submitted to the magazine of Finnish 
Physiotherapy association, which reaches about 9000 individuals 7 times per year. The results will be 
published in Bachelor thesis of Tomas Cervinka. The results may also be presented in national scientific 
conferences to facilitate knowledge translation to researchers and health care providers. 
Conflict of Interest 
Investigators do not have any financial conflicts of interest and have only the interest in completing this 
study as results will be used as a part of Bachelor thesis of Tomas Cervinka. However, this interest will not 
influence decision made by eligible individuals to participate in this study. 
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